Erik Klok
Hoogleraar interne geneeskunde
- Naam
- Prof.dr. F.A. Klok
- Telefoon
- +31 71 526 52981
- f.a.klok@lumc.nl
- ORCID iD
- 0000-0001-9961-0754
Erik Klok is Hoogleraar Interne Geneeskunde en Internist Vasculaire Geneeskunde in het Leids universitair Medisch Centrum. Hij is opleider vasculaire geneeskunde, medisch leider van de trombosedienst leiden en gastwetenschapper aan de Universiteit van Mainz (Duitsland). Hij is voorzitter van de LUMC commissie Good Research Practice, Toelatingscommissie Master Geneeskunde en Commissie selectie en plaatsing, en tevens van de Nederlandse Vereniging voor Internisten Vasculaire Geneeskunde, Dutch Thrombosis Network, EXPERT-PE Europe en aankomende voorzitter van de ESC werkgroep over pulmonale circulatie en rechter ventrikel functie.
Meer informatie over Erik Klok
Erik Klok is Hoogleraar Interne Geneeskunde en Internist Vasculaire Geneeskunde in het Leids universitair Medisch Centrum. Hij is opleider vasculaire geneeskunde, medisch leider van de trombosedienst leiden en gastwetenschapper aan de Universiteit van Mainz (Duitsland). Hij is voorzitter van de LUMC commissie Good Research Practice, Toelatingscommissie Master Geneeskunde en Commissie selectie en plaatsing, en tevens van de Nederlandse Vereniging voor Internisten Vasculaire Geneeskunde, Dutch Thrombosis Network, EXPERT-PE Europe en aankomende voorzitter van de ESC werkgroep over pulmonale circulatie en rechter ventrikel functie.
Vasculaire geneeskunde
Erik Klok is benoemd tot hoogleraar Interne Geneeskunde, in het bijzonder de vasculaire geneeskunde. Eén van de hoofddoelen van zijn studies is het ontwerpen van diagnostische strategieën voor patiënten met verdenking op veneuze trombose om op een zo efficiënt mogelijke manier tot een zo nauwkeurige mogelijke diagnose te komen, waarbij moderne beeldvormende technieken gericht worden ingezet. Een tweede doel is het verbeteren van de acute zorg voor de meest bedreigde patiënten met longembolie, waarbij adequate risicostratificatie, optimaal inzetten van geavanceerde interventies en een multidisciplinaire benadering tot een betere overleving moet leiden. Een laatste doel is het meetbaar maken van de lange termijn uitkomsten van de zorg voor patiënten met veneuze trombose en de introductie van uitkomstgerichte zorg voor deze patiënten categorie.Erik Klok is benoemd tot hoogleraar Interne Geneeskunde, in het bijzonder de vasculaire geneeskunde. Eén van de hoofddoelen van zijn studies is het ontwerpen van diagnostische strategieën voor patiënten met verdenking op veneuze trombose om op een zo efficiënt mogelijke manier tot een zo nauwkeurige mogelijke diagnose te komen, waarbij moderne beeldvormende technieken gericht worden ingezet. Een tweede doel is het verbeteren van de acute zorg voor de meest bedreigde patiënten met longembolie, waarbij adequate risicostratificatie, optimaal inzetten van geavanceerde interventies en een multidisciplinaire benadering tot een betere overleving moet leiden. Een laatste doel is het meetbaar maken van de lange termijn uitkomsten van de zorg voor patiënten met veneuze trombose en de introductie van uitkomstgerichte zorg voor deze patiënten categorie.
Wetenschappelijke carrière
Erik Klok is op 3 maart 2010 laude gepromoveerd op zijn proefschrift “Pulmonary embolism: diagnostic management and prognosis” (https://ap.lc/bpMrq). Zijn oratie getiteld “Veneuze trombo-embolie anno 2023: mag het een onsje minder wezen?” sprak hij uit op 10 maart 2023.
Hoogleraar interne geneeskunde
- Faculteit Geneeskunde
- Divisie 2
- Interne Geneeskunde
- Horst, S.F.B. van der; Jong, Y. de; Rein, N. van; Jukema, J.W.; Palmen, M.; Janssen, E.; Bonneville, E.F.; Klok, F.A.; Huisman, M.V.; Tops, L.F. & Exter, P.L. den (2024), Performance of risk scores in predicting major bleeding in left ventricular assist device recipients, Research and Practice in Thrombosis and Haemostasis 8(4).
- Zian, A.; Overdevest, G.M.; Schutte, P.J.; Klok, F.A.; Steyerberg, E.W.; Moojen, W.A. & Gaag, N.A. van der (2024), Aspin: neurosurgical aspirin intervention prognostic study, Trials 25(1).
- Sissingh, N.J.; Timmerhuis, H.C.; Groen, J.; Jong, M.J.P. de; Besselink, M.G.; Boekestijn, B.; Bollen, T.L.; Bonsing, B.A.; Bouwense, S.A.W.; Hazen, W.L.; Klok, F.A.; Santvoort, H.C. van; Eijck, C.H.J. van; Verdonk, R.C.; Mieog, J.S.D.; Hooft, J.E. van & Dutch Pancreatitis Study Grp (2024), Splanchnic vein thrombosis in necrotizing pancreatitis, HPB 26(4): 548-557.
- Kaptein, F.H.J.; Stöger, J. L.; Dam, L.F. van; Ninaber, M.K.; Mertens, B.J.A.; Huisman, M.V.; Klok, F.A. & Kroft, L.J.M. (2024), Computed tomography diagnosis of pulmonary infarction in acute pulmonary embolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 241.
- Ingemann-Molden, S.; Caspersen, C.K.; Rolving, N.; Hojen, A.A.; Klok, F.A.; Grove, E.L.; Brocki, B.C. & Andreasen, J. (2024), Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 233: 69-81.
- Klok, F. A. E.; Exter, P. L. den; Bosma, M. & Eikenboom, H. (2023), Anti-Xa-activiteit bij laagmoleculairgewicht heparine, Nederlands Tijdschrift voor Geneeskunde 167.
- Lafeber, M.; Evers, A. W. M. & Klok, F. A. (2023), Nocebo-effecten van statines, Nederlands Tijdschrift voor Geneeskunde 167.
- Anijs, R.J.S.; Chen, Q.; Hulle, T. van der; Versteeg, H.H.; Klok, F.A.; Lijfering, W.M. & Cannegieter, S.C. (2023), Venous and arterial thromboembolism after colorectal cancer in the Netherlands, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 229: 90-98.
- Kempers, E.K.; Chen, Q.G.; Visser, C.; Gorp, E.C.M. van; Klok, F.A.; Cannegieter, S.C. & Kruip, M.J.H.A. (2023), Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020, Scientific Reports 13(1).
- Kapteijn, M.Y.; Lanting, V.R.; Kaptein, F.H.J.; Guman, N.A.M.; Laghmani, E.H.; Kuipers, T.B.; Mei, H.L.; Goeman, J.J.; Mulder, F.I.; Duinen, S.G. van; Taphoorn, M.J.B.; Dirven, L.; Broekman, M.L.D.; Es, N. van; Klok, F.A.; Koekkoek, J.A.F.; Versteeg, H.H. & Buijs, J.T. (2023), RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 232: 27-34.
- Jong, C.M.M. de; Hout, W.B. van den; Dijk, C.E. van; Heim, N.; Dam, L.F. van; Dronkers, C.E.A.; Gautam, G.; Ghanima, W.; Gleditsch, J.; Heijne, A. von; Hofstee, H.M.A.; Hovens, M.M.C.; Huisman, M.V.; Kolman, S.; Mairuhu, A.T.A.; Mens, T.E. van; Nijkeuter, M.; Ree, M.A. van de; Rooden, C.J. van; Westerbeek, R.E.; Westerink, J.; Westerlund, E.; Kroft, L.J.M. & Klok, F.A. (2023), Cost-effectiveness of performing reference ultrasonography in patients with deep vein thrombosis, Thrombosis and Haemostasis 124(06).
- Steiner, D.; Nopp, S.; Weber, B.; Schlager, O.; Konigsbrngge, O.; Klok, F.A.; Pabinger, I. & Ay, C. (2023), The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 221: 1-6.
- Kapteijn, M.Y.; Kaptein, F.H.J.; Stals, M.A.M.; Klaase, E.E.; Eijk, R. van; Ruano, D.; Duinen, S.G. van; Cannegieter, S.C.; Taphoorn, M.J.B.; Dirven, L.; Koekkoek, J.A.F.; Klok, F.A.; Versteeg, H.H.; Buijs, J.T. & Garcia-Ortiz, I. (2023), Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 221: 10-18.
- Kaptein, F.H.J.; Stals, M.A.M.; Evenhuis, R.E.; Gelderblom, H.; Huisman, M.V.; Karis, D.S.A.; Noten, R.W.D.; Cannegieter, S.C.; Speetjens, F.M.; Verschoor, A.J.; Versteeg, H.H.; Sande, M.A.J. van de & Klok, F.A. (2023), Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 221: 19-25.
- Kaptein, F.H.J.; Guman, N.A.M.; Es, N. van; Kamphuisen, P.W.; Klok, F.A.; Mairuhu, A.T.A. & Huisman, M.V. (2023), Treatment and prevention of cancer-associated thrombosis in the Netherlands, Research and Practice in Thrombosis and Haemostasis 7(1).
- Willems, R.A.L.; Michiels, N.; Lanting, V.R.; Bouwense, S.; Broek, B.L.J. van den; Graus, M.; Klok, F.A.; Koerkamp, B.G.; Laat, B. de; Roest, M.; Wilmink, J.W.; Es, N. van; Mieog, J.S.D.; Cate, H. ten & Vos-Geelen, J. de (2023), Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care, Cancers 15(14).
- Wiegers, H.M.G.; Knijp, J.; , N. van; Coppens, M.; Klok, F.A.; Middeldorp, S. & Moll, S. (2023), Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates, Journal of Thrombosis and Haemostasis 21(1): 175-178.
- Maanen, R. van; Martens, E.S.L.; Takada, T.; Roy, P.M.; Wit, K. de; Parpia, S.; Kraaijpoel, N.; Huisman, M.; Wells, P.S.; Gal, G. le; Righini, M.; Freund, Y.; Galipienzo, J.; Es, N. van; Blom, J.W.; Moons, K.G.M.; Rutten, F.H.; Smeden, M. van; Klok, F.A.; Geersing, G.J. & Luijken, K. (2023), Accuracy of physicians' intuitive risk estimation in the diagnostic management of pulmonary embolism, Journal of Thrombosis and Haemostasis 21(10): 2873-2883.
- Barco, S.; Klok, F.A. & Bikdeli, B. (2023), Optimizing and extending the risk-adapted management of acute pulmonary embolism beyond the acute phase, Seminars in Thrombosis and Hemostasis 49(8).
- Jervan, O.; Haukeland-Parker, S.; Gleditsch, J.; Tavoly, M.; Klok, F.A.; Steine, K.; Johannessen, H.H.; Spruit, M.A.; Atar, D.; Holst, R.; Dahm, A.E.A.; Sirnes, P.A.; Stavem, K. & Ghanima, W. (2023), The effects of exercise training in patients with persistent dyspnea following pulmonary embolism, Chest Journal 164(4): 981-991.
- Vlieg, M.A.M.V.; Nasserinejad, K.; Visser, C.; Bramer, W.M.; Ashrani, A.A.; Bosson, J.L.; Crusan, D.J.; D'Alessio, A.; Fluharty, M.E.; Gibietis, V.; Hansson, P.O.; Hara, N.; Jara-Palomares, L.; Kraaijpoel, N.; Mahé, I.; Marshall, A.; Ogino, Y.; Otero, R.; Versmissen, J.; Klok, F.A.; Kruip, M.H.A.; Rijt, C.C.D. van der & Geijtemana, E.C.T. (2023), The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis, EClinicalMedicine 64.
- Chu, G.R.; Seelig, J.; Cannegieter, S.C.; Gelderblom, H.; Hovens, M.M.C.; Huisman, M.V.; Hulle, T. van der; Trines, S.A.; Vlot, A.J.; Versteeg, H.H.; Hemels, M. & Klok, F.A. (2023), Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 230: 98-104.
- Jong, C.M.M. de; Wit, K. de; Black, S.A.; Gwozdz, A.M.; Masias, C.; Parks, A.L.; Robert-Ebadi, H.; Talerico, R.; Woller, S.C. & Klok, F.A. (2023), Use of patient-reported outcome measures in patients with venous thromboembolism, Journal of Thrombosis and Haemostasis 21(10): 2953-2962.
- Humbert, M.; Kovacs, G.; Hoeper, M.M.; Badagliacca, R.; Berger, R.M.F.; Brida, M.; Carlsen, J.; Coats, A.J.S.; Escribano-Subias, P.; Ferrari, P.; Ferreira, D.S.; Ghofrani, H.A.; Giannakoulas, G.; Kiely, D.G.; Mayer, E.; Meszaros, G.; Nagavci, B.; Olsson, K.M.; Pepke-Zaba, J.; Quint, J.K.; Rådegran, G.; Simonneau, G.; Sitbon, O.; Tonia, T.; Toshner, M.; Vachiery, J.L.; Noordegraaf, A.V.; Delcroix, M.; Rosenkranz, S.; Schwerzmann, M.; Dinh-Xuan, A.T.; Bush, A.; Abdelhamid, M.; Aboyans, V.; Arbustini, E.; Asteggiano, R.; Barberà, J.A.; Beghetti, M.; Celutkiene, J.; Cikes, M.; Condliffe, R.; Man, F. de; Falk, V.; Fauchier, L.; Gaine, S.; Galiè, N.; Gin-Sing, W.; Granton, J.; Grünig, E.; Hassoun, P.M.; Hellemons, M.; Jaarsma, T.; Kjellström, B.; Klok, F.A.; Konradi, A.; Koskinas, K.C.; Kotecha, D.; Lang, I.; Lewis, B.S.; Linhart, A.; Lip, G.Y.H.; Lochen, M.L.; Mathioudakis, A.G.; Mindham, R.; Moledina, S.; Naeije, R.; Prescott, E.; Rakisheva, A.; Reis, A.; Ristic, A.D.; Nielsen, J.C.; Olschewski, H.; Opitz, I.; Petersen, S.E. & ESC ERS Sci Document Grp (2023), 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension, GIORNALE ITALIANO DI CARDIOLOGIA 24(4): E1-E116.
- Zhai, Z.W.; Boon, G.J.A.M.; Staring, M.; Dam, L.F. van; Kroft, L.J.M.; Girón, I.H.; Ninaber, M.K.; Bogaard, H.J.; Meijboom, L.J.; Noordegraaf, A.V.; Huisman, M.V.; Klok, F.A. & Stoel, B.C. (2023), Automated quantification of the pulmonary vasculature in pulmonary embolism and chronic thromboembolic pulmonary hypertension, Pulmonary Circulation 13(2).
- Trinks-Roerdink, E.M.; Geersing, G.J.; Hemels, M.E.W.; Gelder, I.C. van; Klok, F.A.; Smeden, M. van; Rutten, F.H. & Doorn, S. van (2023), External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants, Open Heart 10(1).
- Horst, S.F.B. van der; Exter, P.L. den; Huisman, M.V. & Klok, F.A. (2023), Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 228: 21-32.
- Kaptein, F.H.J.; Kroft, L.J.M.; Dam, L.F. van; Stöger, J.L.; Ninaber, M.K.; Huisman, M.V. & Klok, F.A. (2023), Impact of pulmonary infarction in pulmonary embolism on presentation and outcomes, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 226: 51-55.
- Horst, S.F.B. van der; Rein, N. van; Mens, T.E. van; Huisman, M.V. & Klok, F.A. (2023), Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 231: 135-140.
- Stals, M.A.M.; Beenen, L.F.M.; Coppens, M.; Faber, L.M.; Hofstee, H.M.A.; Hovens, M.M.C.; Huisman, M.V.; Hulle, T.V.; Kaasjager, K.A.H.; Kruip, M.J.H.A.; Mairuhu, A.T.A.; Middeldorp, S.; Wolde, M. ten; Es, N. van; YEARS Study Grp & Klok, F.A. (2023), Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 231: 65-75.
- Groeneveld, N.T.A.; Swier, C.E.L.; Montero-Cabezas, J.; Kraemer, C.V.E.; Klok, F.A. & Brink, F.S. van den (2023), Mechanical Support Strategies for High-Risk Procedures in the Invasive Cardiac Catheterization Laboratory: A State-of-the-Art Review, Journal of Clinical Medicine 12(24).
- Marin-Romero, S.; Ballaz-Quincoces, A.; Gómez-Cuervo, C.; Marchena-Yglesias, P.J.; Lopez-Miguel, P.; Francisco-Albesa, I.; Pedrajas-Navas, J.M.; Lumbierres, M.; Aibar-Arregui, M.A.; Lopez-Saez, J.B.; Perez-Pinar, M.; Baeza-Martinez, C.; Riera-Mestre, A.; Peris-Sifre, M.; Porras-Ledantes, J.A.; Criado-Garcia, J.; Elias-Hernandez, T.; Otero, R.; Barca-Hernando, M.; Muriel, A.; Klok, F.A.; Jara-Palomares, L. & SYSPPE investigators (2023), Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Thorax 79.
- Buijs, J.T.; Beijnum, R. van; Anijs, R.J.S.; Laghmani, E.; Sensuk, L.; Minderhoud, C.; Ünlü, B.; Klok, F.A.; Kuppen, P.J.K.; Cannegieter, S.C. & Versteeg, H.H. (2023), The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancer, Journal of Thrombosis and Thrombolysis 57.
- Gleditsch, J.; Jervan, O.; Klok, F.; Holst, R.; Hopp, E.; Tavoly, M. & Ghanima, W. (2023), Does the clot burden as assessed by the Mean Bilateral Proximal Extension of the Clot score reflect mortality and adverse outcome after pulmonary embolism?, Acta Radiologica Open 12(6).
- Luijten, D.; Talerico, R.; Barco, S.; Cannegieter, S.C.; Delcroix, M.; Ende-Verhaar, Y.M.; Huisman, M.V.; Konstantinidis, S.; Mairuhu, A.T.A.; Mens, T.E. van; Ninaber, M.; Pruszczyk, P.; Noordegraaf, A.V. & Klok, F.A. (2023), Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis, European Respiratory Journal 62(1).
- Klok, F.A. & Siegerink, B. (2023), Ordinal outcomes add value to clinical trials, The Lancet 401(10381): 995-995.
- Sissingh, N.J.; Groen, J.V.; Timmerhuis, H.C.; Besselink, M.G.; Boekestijn, B.; Bollen, T.L.; Bonsing, B.A.; Klok, F.A.; Santvoort, H.C. van; Verdonk, R.C.; Eijck, C.H.J. van; Hooft, J.E. van & Mieog, J.S.D. (2023), Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis, World Journal of Gastroenterology 29(21): 3328-3340.
- Jong, C.M.M. de; , Y.N.J. le; Boon, G.J.A.M.; Barco, S.; Klok, F.A. & Siegerink, B. (2023), Eight lessons from 2 years of use of the Post-COVID-19 Functional Status scale, European Respiratory Journal 61(5).
- Jong, C.M.M. de; Visser, C.; Bemelmans, R.H.H.; Boersma, W.G.; Borst, B. van den; Burggraaf, J.L.I.; Cannegieter, S.C.; Cate-Hoek, A.J. ten; Croles, F.N.; Faber, H.J.; Faber, L.M.; Hellemons, M.E.; Hessels, L.M.; Huisman, M.; Kamphuisen, P.W.; Koster, S.C.E.; Kroft, L.J.M.; Lee, I. van der; Leentjens, J.; Meijer, K.; Ninaber, M.K.; Sondermeijer, B.M.; Stads, S.; Noordegraaf, A.V.; Winckers, K.; Kruip, M.J.H.A.; Klok, F.A. & Dutch COVID Thrombosis Coalition (2023), Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism, European Respiratory Journal 61(4).
- Burggraaf, J.L.I.; Rein, N. van; Klok, F.A. & Cannegieter, S.C. (2023), How to predict recurrent venous thromboembolism and bleeding? A review of recent advances and their implications, Polskie Archiwum Medycyny Wewn�trznej 133(5).
- Jong, C.M.M. de; Boon, G.J.A.M.; , Y.N.J. le; Barco, S.; Siegerink, B. & Klok, F.A. (2023), The post-venous thromboembolism functional status scale, Seminars in Thrombosis and Hemostasis 49(7): 764-773.
- (2023), Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation, Thrombosis Haemostasis Open.
- Talasaz, A.H.; Sadeghipour, P.; Bakhshandeh, H.; Sharif-Kashani, B.; Rashidi, F.; Beigmohammadi, M.T.; Moghadam, K.G.; Rezaian, S.; Dabbagh, A.; Sezavar, S.H.; Farrokhpour, M.; Abedini, A.; Aliannejad, R.; Riahi, T.; Yadollahzadeh, M.; Lookzadeh, S.; Rezaeifar, P.; Matin, S.; Tahamtan, O.; Mohammadi, K.; Zoghi, E.; Rahmani, H.; Hosseini, S.H.; Mousavian, S.M.; Abri, H.; Sadeghipour, P.; Baghizadeh, E.; Rafiee, F.; Jamalkhani, S.; Amin, A.; Mohebbi, B.; Parhizgar, S.E.; Soleimanzadeh, M.; Aghakouchakzadeh, M.; Eslami, V.; Payandemehr, P.; Khalili, H.; Talakoob, H.; Tojari, T.; Shafaghi, S.; Tabrizi, S.; Kakavand, H.; Kashefizadeh, A.; Najafi, A.; Jimenez, D.; Gupta, A.; Madhavan, M.V.; Sethi, S.S.; Parikh, S.A.; Monreal, M.; Hadavand, N.; Hajighasemi, A.; Ansarin, K.; Maleki, M.; Sadeghian, S.; Barco, S.; Siegerink, B.; Spatz, E.S.; Piazza, G.; Kirtane, A.J.; Tassell, B.W.V.; Lip, G.Y.H.; Klok, F.A.; Goldhaber, S.Z.; Stone, G.W.; Krumholz, H.M. & Bikdeli, B. (2023), Atorvastatin versus placebo in ICU patients with COVID-19, Thrombosis and Haemostasis 123(07): 723-733.
- Font, J.; Milliez, P.; Ouazar, A.B.; Klok, F.A. & Alexandre, J. (2023), Atrial fibrillation, cancer and anticancer drugs, Archives of Cardiovascular Diseases 116(4): 219-226.
- Chu, G.R.; Seelig, J.; Cannegieter, S.C.; Gelderblom, H.; Hovens, M.M.C.; Huisman, M.V.; Hulle, T.V.; Trines, S.A.; Vlot, A.J.; Versteeg, H.H.; Hemels, M.E.W. & Klok, F.A. (2023), Atrial fibrillation in cancer: thromboembolism and bleeding in daily practice, Research and Practice in Thrombosis and Haemostasis 7(2).
- Luijten, D.; Klok, F.A.; Mens, T.E. van & Huisman, M. (2023), Clinical controversies in the management of acute pulmonary embolism, Expert Review of Respiratory Medicine 17(3): 181-189.
- Lee, J.Y.; Es, N. van; Takada, T.; Klok, F.A.; Geersing, G.J.; Blume, J.; Bossuyt, P.M. & IPD study team (2023), Covariate-specific ROC curve analysis can accommodate differences between covariate subgroups in the evaluation of diagnostic accuracy, Journal of Clinical Epidemiology 160: 14-23.
- Mehdizadeh, K.; Salehi, M.M.; Moosavi, J.; Mohebbi, B.; Klok, F.A.; Bikdeli, B.; Shafe, O.; Pouraliakbar, H.; Alizadehasl, A.; Farrashi, M.; Kaviani, R.; Mehrvarz, F.; Rashidi, F.; Talakoob, H.; Bakhshandeh, H. & Sadeghipour, P. (2023), Cross-cultural validity of the Pulmonary Embolism Quality of Life questionnaire in the quality of life survey after pulmonary embolism, Research and Practice in Thrombosis and Haemostasis 7(3).
- Jervan, O.; Dhayyat, A.; Gleditsch, J.; Haukeland-Parker, S.; Tavoly, M.; Klok, F.A.; Rashid, D.; Stavem, K.; Ghanima, W. & Steine, K. (2023), Demographic, clinical, and echocardiographic factors associated with residual perfusion defects beyond six months after pulmonary embolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 229: 7-14.
- Bikdeli, B.; , Y.C. lo; Khairani, C.D.; Bejjani, A.; Jimenez, D.; Barco, S.; Mahajan, S.; Caraballo, C.; Secemsky, E.A.; Klok, F.A.; Hunsaker, A.R.; Aghayev, A.; Muriel, A.; Wang, Y.; Hussain, M.A.; Appah-Sampong, A.; Lu, Y.; Lin, Z.Q.; Aneja, S.; Khera, R.; Goldhaber, S.Z.; Zhou, L.; Monreal, M.; Krumholz, H.M. & Piazza, G. (2023), Developing validated tools to identify pulmonary embolism in electronic databases, Thrombosis and Haemostasis 123(06): 649-662.
- Es, N. van; Takada, T.; Kraaijpoel, N.; Klok, F.A.; Stals, M.A.M.; Büller, H.R.; Courtney, D.M.; Freund, Y.; Galipienzo, J.; Gal, G. le; Ghanima, W.; Huisman, M.; Kline, J.A.; Moons, K.G.M.; Parpia, S.; Perrier, A.; Righini, M.; Robert-Ebadi, H.; Roy, P.M.; Wells, P.S.; Wit, K. de; Smeden, M. van & Geersing, G.J. (2023), Diagnostic management of acute pulmonary embolism, European Heart Journal 44(32): 3073-+.
- Talerico, R.; Pola, R.; Huisman, M.V. & Klok, F.A. (2023), DOACs plasma levels in relation to clinical outcome. How far have we come?, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 225: 16-21.
- Chu, G.; Valerio, L.; Barco, S.; Huisman, M.V.; Konstantinides, S.V. & Klok, F.A. (2023), External validation of AF-BLEED for predicting major bleeding and for tailoring NOAC dose in AF patients, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 229: 225-231.
- Wang, H.J.; Klok, F.A.; Rosendaal, F.R.; Cushman, M. & Vlieg, A.V. (2023), Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older, Research and Practice in Thrombosis and Haemostasis 7(5).
- Simonneau, G.; Fadel, E.; Noordegraaf, A.V.; Toshner, M.; Lang, I.M.; Klok, F.A.; McInnis, M.C.; Screaton, N.; Madani, M.M.; Martinez, G.; Salaunkey, K.; Jenkins, D.P.; Matsubara, H.; Brénot, P.; Hoeper, M.M.; Ghofrani, H.A.; Jaïs, X.; Wiedenroth, C.B.; Guth, S.; Kim, N.H.; Pepke-Zaba, J.; Delcroix, M. & Mayer, E. (2023), Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021, European Respiratory Review 32(167).
- Stals, M.A.M.; Moumneh, T.; Ainle, F.N.; Aujesky, D.; Bemmel, T. van; Bertoletti, L.; Bistervels, I.M.; Chauleur, C.; Couturaud, F.; Dooren, Y.P.A. van; Elias, A.; Faber, L.M.; Gall, C. le; Hofstee, H.M.A.; Hulle, T.V.; Kruip, M.J.H.A.; Maignan, M.; Mairuhu, A.T.A.; Middeldorp, S.; Moigne, E. le; Nijkeuter, M.; Pol, L.M. van der; Robert-Ebadi, H.; Roy, P.M.; Sanchez, O.; Schmidt, J.; Smeden, M. van; Tromeur, C.; Wolde, M. ten; Righini, M.; Gal, G. le; Huisman, M.V. & Klok, F.A. (2023), Noninvasive diagnostic work-up for suspected acute pulmonary embolism during pregnancy: a systematic review and meta-analysis of individual patient data, Journal of Thrombosis and Haemostasis 21(3): 606-615.
- Jong, C.M.M. de; Rosovsky, R.P. & Klok, F.A. (2023), Outcomes of venous thromboembolism care: future directions, Journal of Thrombosis and Haemostasis 21(5): 1082-1089.
- Mulder, F.I.; Kraaijpoel, N.; Carrier, M.; Guman, N.A.; Jara-Palomares, L.; Nisio, M. di; Ageno, W.; Beyer-Westendorf, J.; Klok, F.A.; Vanassche, T.; Otten, H.M.B.; Cosmi, B.; Wolde, M. ten; Veld, S.G.J.G.I.; Post, E.; Ramaker, J.; Zwaan, K.; Peters, M.; Delluc, A.; Kamphuisen, P.W.; Sanchez-Lopez, V.; Porreca, E.; Bossuyt, P.M.M.; Büller, H.R.; Wurdinger, T.; Best, M.G. & Es, N. van (2023), Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism, Journal of Thrombosis and Haemostasis 21(4): 905-916.
- Barco, S.; Mavromanoli, A.C.; Kreitner, K.F.; Bunck, A.C.; Gertz, R.J.; Ley, S.; Valerio, L.; Klok, F.A.; Gerhardt, F.; Rosenkranz, S. & Konstantinides, S.V. (2023), Preexisting chronic thromboembolic pulmonary hypertension in acute pulmonary embolism, Chest Journal 163(4): 923-932.
- Luijten, D.; Klok, F.A.; Mens, T.E. van & Huisman, M.V. (2023), Response to letter to the editor: "Clinical controversies in the management of acute pulmonary embolism: evaluation of four important but controversial aspects of acute pulmonary embolism management that are still subject of debate and research", Expert Review of Respiratory Medicine 17(6): 427-428.
- Vedovati, M.C.; Giustozzi, M.; Munoz, A.; Bertoletti, L.; Cohen, A.T.; Klok, F.A.; Connors, J.M.; Bauersachs, R.; Brenner, B.; Campanini, M.; Becattini, C. & Agnelli, G. (2023), Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism, European Journal of Internal Medicine 112: 29-36.
- Munblit, D.; Nicholson, T.; Akrami, A.; Apfelbacher, C.; Chen, J.; Groote, W. de; Diaz, J.V.; Gorst, S.L.; Harman, N.; Kokorina, A.; Olliaro, P.; Parr, C.; Preller, J.; Schiess, N.; Schmitt, J.; Seylanova, N.; Simpson, F.; Tong, A.; Needham, D.M.; Williamson, P.R. & PC-COS Project Steering Committee (2022), A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research, The Lancet Respiratory Medicine 10(7): 715-724.
- Klok, F.A.; Ageno, W.; Ay, C.; Back, M.; Barco, S.; Bertoletti, L.; Becattini, C.; Carlsen, J.; Delcroix, M.; Es, N. van; Huisman, M.V.; Jara-Palomares, L.; Konstantinides, S.; Lang, I.; Meyer, G.; Ainle, F.N.; Rosenkranz, S. & Pruszczyk, P. (2022), Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society, European Heart Journal 43(3): 183-189.
- Cuker, A.; Tseng, E.K.; Nieuwlaat, R.; Angchaisuksiri, P.; Blair, C.; Dane, K.; Davila, J.; DeSancho, M.T.; Diuguid, D.; Griffin, D.O.; Kahn, S.R.; Klok, F.A.; Lee, A.I.; Neumann, I.; Pai, A.; Righini, M.; Sanfilippo, K.M.; Siegal, D.; Skara, M.; Terrell, D.R.; Touri, K.; Akl, E.A.; Jabiri, R.N. al; Jabiri, Y.N. al; Barbara, A.M.; Bognanni, A.; Akl, I.B.; Boulos, M.; Brignardello-Petersen, R.; Charide, R.; Chan, M.; Colunga-Lozano, L.E.; Dearness, K.; Darzi, A.J.; Hussein, H.; Karam, S.G.; Kolb, P.; Mansour, R.; Morgano, G.P.; Morsi, R.Z.; Muti-Schunemann, G.; Nadim, M.K.; Noori, A.; Philip, B.A.; Piggott, T.; Qiu, Y.; Benitez, Y.R.; Schunemann, F.; Stevens, A.; Solo, K.; Wiercioch, W.; Mustafa, R.A. & Schunemann, H.J. (2022), American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19, Blood Advances 6(2): 664-671.
- Klok, F.A.; Piazza, G.; Sharp, A.S.P.; Ainle, F.N.; Jaff, M.R.; Chauhan, N.; Patel, B.; Barco, S.; Goldhaber, S.Z.; Kucher, N.; Lang, I.M.; Schmidtmann, I.; Sterling, K.M.; Becker, D.; Martin, N.; Rosenfield, K. & Konstantinides, S.V. (2022), Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism, American Heart Journal 251: 43-53.
- Anijs, R.J.S.; Laghmani, E.; Unlu, B.; Kielbasa, S.M.; Mei, H.L.; Cannegieter, S.C.; Klok, F.A.; Kuppen, P.J.K.; Versteeg, H.H. & Buijs, J.T. (2022), Tumor-expressed microRNAs associated with venous thromboembolism in colorectal cancer, Research and Practice in Thrombosis and Haemostasis 6(5).
- Wiegers, H.M.G.; Knijp, J.; Es, N. van; Coppens, M.; Moll, S.; Klok, F.A. & Middeldorp, S. (2022), Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis, Journal of Thrombosis and Haemostasis 20(5): 1158-1165.
- Lith, T.J. van; Sluis, W.M.; Wijers, N.T.; Meijer, F.J.A.; Kamphuis-van Ulzen, K.; Bresser, J. de; Dankbaar, J.W.; Heuvel, F.M.A. van den; Antoni, M.L.; Mulders-Manders, C.M.; Mast, Q. de; Veerdonk, F.L. van de; Klok, F.A.; Tuladhar, A.M.; Cannegieter, S.C.; Wermer, M.J.H.; Worp, H.B. van der; Huisman, M.V. & Leeuw, F.E. de (2022), Prevalence, risk factors, and long-term outcomes of cerebral ischemia in hospitalized COVID-19 patients - study rationale and protocol of the CORONIS study, European Stroke Journal 7(2).
- Exter, P.L. den; Woller, S.C.; Robert-Ebadi, H.; Masias, C.; Morange, P.E.; Castelli, D.; Hansen, J.B.; Geersing, G.J.; Siegal, D.M.; Wit, K. de & Klok, F.A. (2022), Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism, Journal of Thrombosis and Haemostasis 20(8): 1910-1919.
- Kaptein, F.H.J.; Stals, M.A.M.; Kapteijn, M.Y.; Cannegieter, S.C.; Dirven, L.; Duinen, S.G. van; Eijk, R. van; Huisman, M.V.; Klaase, E.E.; Taphoorn, M.J.B.; Versteeg, H.H.; Buijs, J.T.; Koekkoek, J.A.F. & Klok, F.A. (2022), Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma, Journal of Thrombosis and Haemostasis 20(7).
- Huisman, M.V. & Klok, F.A. (2022), First do no harm, Research and Practice in Thrombosis and Haemostasis 6(3).
- Nab, L.; Groenwold, R.H.H.; Klok, F.A.; Bhoelan, S.; Kruip, M.J.H.A. & Cannegieter, S.C. (2022), Estimating incidence of venous thromboembolism in COVID-19, Research and Practice in Thrombosis and Haemostasis 6(6).
- Martens, E.S.L.; Huisman, M.V. & Klok, F.A. (2022), Diagnostic Management of Acute Pulmonary Embolism in COVID-19 and Other Special Patient Populations, Diagnostics 12(6).
- Woller, S.C.; Wit, K. de; Robert-Ebadi, H.; Masias, C.; Klok, F.A.; Exter, P.L. den; Morange, P.E.; Castelli, D. & Hansen, J.B. (2022), A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH, Research and Practice in Thrombosis and Haemostasis 6(6).
- Nopp, S.; Moik, F.; Klok, F.A.; Gattinger, D.; Petrovic, M.; Vonbank, K.; Koczulla, A.R.; Ay, C. & Zwick, R.H. (2022), Outpatient pulmonary rehabilitation in patients with Long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life, Respiration 101(6).
- Bavalia, R.; Stals, M.A.M.; Mulder, F.I.; Bistervels, I.M.; Coppens, M.; Faber, L.M.; Hendriks, S.V.; Hofstee, H.M.A.; Huisman, M.V.; Hulle, T. van der; Mairuhu, A.T.A.; Kruip, M.J.H.A.; Middeldorp, S.; Klok, F.A.; Hutten, B.A. & Holleman, F. (2022), Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism, Emergency Medicine Journal 40.
- Sissingh, N.J.; Groen, J.V.; Koole, D.; Klok, F.A.; Boekestijn, B.; Bollen, T.L.; Santvoort, H.C. van; Verdonk, R.C.; Bonsing, B.A.; Eijck, C.H.J. van; Hooft, J.E. van; Mieog, J.S.D. & Dutch Pancreatitis Study Grp (2022), Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: A systematic review and meta-analysis, Pancreatology 22(2): 235-243.
- Turatti, G.; Fedeli, U.; Valerio, L.; Klok, F.A.; Cohen, A.T.; Hunt, B.J.; Simioni, P.; Middeldorp, S.; Ageno, W.; Kucher, N.; Konstantinides, S.V.; Schievano, E. & Barco, S. (2022), Splanchnic vein thrombosis-related mortality in the Veneto region (Italy), 2008-2019, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 209: 41-46.
- Mavromanoli, A.C.; Barco, S.; Ageno, W.; Bouvaist, H.; Brodmann, M.; Cuccia, C.; Couturaud, F.; Dellas, C.; Dimopoulos, K.; Duerschmied, D.; Empen, K.; Faggiano, P.; Ferrari, E.; Galie, N.; Galvani, M.; Ghuysen, A.; Giannakoulas, G.; Huisman, M.V.; Jimenez, D.; Kozak, M.; Lang, I.M.; Meneveau, N.; Munzel, T.; Palazzini, M.; Petris, A.O.; Piovaccari, G.; Salvi, A.; Schellong, S.; Schmidt, K.H.; Verschuren, F.; Schmidtmann, I.; Toenges, G.; Klok, F.A.; Konstantinides, S.V. & PEITHO-2 Investigators (2022), Recovery of right ventricular function after intermediate-risk pulmonary embolism, Clinical Research in Cardiology 112.
- Singh, B.; Lant, S.; Cividini, S.; Cattrall, J.W.S.; Goodwin, L.C.; Benjamin, L.; Michael, B.D.; Khawaja, A.; Matos, A.D.B.; Alkeridy, W.; Pilotto, A.; Lahiri, D.; Rawlinson, R.; Mhlanga, S.; Lopez, E.C.; Sargent, B.F.; Somasundaran, A.; Tamborska, A.; Webb, G.; Younas, K.; Sami, Y. al; Babu, H.; Banks, T.; Cavallieri, F.; Cohen, M.; Davies, E.; Dhar, S.; Modol, A.F.; Farooq, H.; Harte, J.; Hey, S.; Joseph, A.; Karthikappallil, D.; Kassahun, D.; Lipunga, G.; Mason, R.; Minton, T.; Mond, G.; Poxon, J.; Rabas, S.; Soothill, G.; Zedde, M.; Yenkoyan, K.; Brew, B.; Contini, E.; Cysique, L.; Zhang, X.; Maggi, P.; Pesch, V. van; Lechien, J.; Saussez, S.; Heyse, A.; Ferreira, M.L.B.; Soares, C.N.; Elicer, I.; Eugenin-von Bernhardi, L.; Reyes, W.N.; Yin, R.; Azab, M.A.; Abd-Allah, F.; Elkady, A.; Escalard, S.; Corvol, J.C.; Delorme, C.; Tattevin, P.; Bigaut, K.; Lorenz, N.; Hornuss, D.; Hosp, J.; Rieg, S.; Wagner, D.; Knier, B.; Lingor, P.; Winkler, A.S.; Sharifi-Razavi, A.; Moein, S.T.; SeyedAlinaghi, S.; JamaliMoghadamSiahkali, S.; Morassi, M.; Padovani, A.; Giunta, M.; Libri, I.; Beretta, S.; Ravaglia, S.; Foschi, M.; Calabresi, P.; Primiano, G.; Servidei, S.; Mercuri, N.B.; Liguori, C.; Pierantozzi, M.; Sarmati, L.; Boso, F.; Garazzino, S.; Mariotto, S.; Patrick, K.N.; Costache, O.; Pincherle, A.; Klok, F.A.; Meza, R.; Cabreira, V.; Valdoleiros, S.R.; Oliveira, V.; Kaimovsky, I.; Guekht, A.; Koh, J.; Diaz, E.F.; Barrios-Lopez, J.M.; Guijarro-Castro, C.; Beltran-Corbellini, A.; Martinez-Poles, J.; Diezma-Martin, A.M.; Morales-Casado, M.I.; Garcia, S.G.; Breville, G.; Coen, M.; Uginet, M.; Bernard-Valnet, R.; Pasquier, R. du; Kaya, Y.; Abdelnour, L.H.; Rice, C.; Morrison, H.; Defres, S.; Huda, S.; Enright, N.; Hassell, J.; D'Anna, L.; Benger, M.; Sztriha, L.; Raith, E.; Chinthapalli, K.; Nortley, R.; Paterson, R.; Chandratheva, A.; Werring, D.J.; Dervisevic, S.; Harkness, K.; Pinto, A.; Jillella, D.; Beach, S.; Gunasekaran, K.; Silva, I.R.F. da; Nalleballe, K.; Santoro, J.; Scullen, T.; Kahn, L.; Kim, C.Y.; Thakur, K.T.; Jain, R.; Umapathi, T.; Nicholson, T.R.; Sejvar, J.J.; Hodel, E.M.; Smith, C.T.; Solomon, T. & Brain Infect Global COVID-Neuro Ne (2022), Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease, PLoS ONE 17(6).
- Ghossein-Doha, C.; Wintjens, M.S.J.N.; Janssen, E.B.N.J.; Klein, D.; Heemskerk, S.C.M.; Asselbergs, F.W.; Birnie, E.; Bonsel, G.J.; Bussel, B.C.T. van; Cals, J.W.L.; Cate, H. ten; Haagsma, J.; Hemmen, B.; Horst, I.C.C. van der; Kietselaer, B.L.J.H.; Klok, F.A.; Kruif, M.D. de; Linschoten, M.; Santen, S. van; Vernooy, K.; Willems, L.H.; Westerborg, R.; Warle, M. & Kuijk, S.M.J. van (2022), Prevalence, pathophysiology, prediction and health-related quality of life of long COVID, BMJ Open 12(11).
- Luijten, D.; Jong, C.M.M. de; Ninaber, M.K.; Spruit, M.A.; Huisman, M.V. & Klok, F.A. (2022), Post-pulmonary embolism syndrome and functional outcomes after acute pulmonary embolism, Seminars in Thrombosis and Hemostasis 49(8).
- Klok, P.F. & Velde, G. van der (2022), Plant traits and environment: floating leaf blade production and turnover of Nymphoides peltata (SG Gmel.) O. Kuntze (Menyanthaceae), PeerJ – the Journal of Life & Environmental Sciences 10.
- Jong, C.M.M. de; Blondon, M.; Ay, C.; Buchmuller, A.; Beyer-Westendorf, J.; Biechele, J.; Bertoletti, L.; Colombo, G.; Donadini, M.P.; Hendriks, S.V.; Jara-Palomares, L.; Nopp, S.; Ruiz-Artacho, P.; Stephan, P.; Tromeur, C.; Vanassche, T.; Westerweel, P.E.; Klok, F.A. & TEAM VTE Investigators (2022), Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism, Blood 140(16): 1764-1773.
- Baigent, C.; Windecker, S.; Andreini, D.; Arbelo, E.; Barbato, E.; Bartorelli, A.L.; Baumbach, A.; Behr, E.R.; Berti, S.; Bueno, H.; Capodanno, D.; Cappato, R.; Chieffo, A.; Collet, J.P.; Cuisset, T.; Simone, G. de; Delgado, V.; Dendale, P.; Dudek, D.; Edvardsen, T.; Elvan, A.; Gonzalez-Juanatey, J.R.; Gori, M.; Grobbee, D.; Guzik, T.J.; Halvorsen, S.; Haude, M.; Heidbuchel, H.; Hindricks, G.; Ibanez, B.; Karam, N.; Katus, H.; Klok, F.A.; Konstantinides, S.V.; Landmesser, U.; Leclercq, C.; Leonardi, S.; Lettino, M.; Marenzi, G.; Mauri, J.; Metra, M.; Morici, N.; Mueller, C.; Petronio, A.S.; Polovina, M.M.; Potpara, T.; Praz, F.; Prendergast, B.; Prescott, E.; Price, S.; Pruszczyk, P.; Rodriguez-Leor, O.; Roffi, M.; Romaguera, R.; Rosenkranz, S.; Sarkozy, A.; Scherrenberg, M.; Seferovic, P.; Senni, M.; Spera, F.R.; Stefanini, G.; Thiele, H.; Tomasoni, D.; Torracca, L.; Touyz, R.M.; Wilde, A.A.; Williams, B. & European Soc Cardiology (2022), European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic, European Heart Journal 43(11): 1033-1058.
- Baigent, C.; Windecker, S.; Andreini, D.; Arbelo, E.; Barbato, E.; Bartorelli, A.L.; Baumbach, A.; Behr, E.R.; Berti, S.; Bueno, H.; Capodanno, D.; Cappato, R.; Chieffo, A.; Collet, J.P.; Cuisset, T.; Simone, G. de; Delgado, V.; Dendale, P.; Dudek, D.; Edvardsen, T.; Elvan, A.; Gonzalez-Juanatey, J.R.; Gori, M.; Grobbee, D.; Guzik, T.J.; Halvorsen, S.; Haude, M.; Heidbuchel, H.; Hindricks, G.; Ibanez, B.; Karam, N.; Katus, H.; Klok, F.A.; Konstantinides, S.V.; Landmesser, U.; Leclercq, C.; Leonardi, S.; Lettino, M.; Marenzi, G.; Mauri, J.; Metra, M.; Morici, N.; Mueller, C.; Petronio, A.S.; Polovina, M.M.; Potpara, T.; Praz, F.; Prendergast, B.; Prescott, E.; Price, S.; Pruszczyk, P.; Rodriguez-Leor, O.; Roffi, M.; Romaguera, R.; Rosenkranz, S.; Sarkozy, A.; Scherrenberg, M.; Seferovic, P.; Senni, M.; Spera, F.R.; Stefanini, G.; Thiele, H.; Tomasoni, D.; Torracca, L.; Touyz, R.M.; Wilde, A.A.; Williams, B. & Task Force Management Covid-19 Eur (2022), European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic, Cardiovascular Research 118(6): 1385-1412.
- Baigent, C.; Windecker, S.; Andreini, D.; Arbelo, E.; Barbato, E.; Bartorelli, A.L.; Baumbach, A.; Behr, E.R.; Berti, S.; Bueno, H.; Capodanno, D.; Cappato, R.; Chieffo, A.; Collet, J.P.; Cuisset, T.; Simone, G. de; Delgado, V.; Dendale, P.; Dudek, D.; Edvardsen, T.; Elvan, A.; Gonzalez-Juanatey, J.R.; Gori, M.; Grobbee, D.; Guzik, T.J.; Halvorsen, S.; Haude, M.; Heidbuchel, H.; Hindricks, G.; Ibanez, B.; Karam, N.; Katus, H.; Klok, F.A.; Konstantinides, S.V.; Landmesser, U.; Leclercq, C.; Leonardi, S.; Lettino, M.; Marenzi, G.; Mauri, J.; Metra, M.; Morici, N.; Mueller, C.; Petronio, A.S.; Polovina, M.M.; Potpara, T.; Praz, F.; Prendergast, B.; Prescott, E.; Price, S.; Pruszczyk, P.; Rodriguez-Leor, O.; Roffi, M.; Romaguera, R.; Rosenkranz, S.; Sarkozy, A.; Scherrenberg, M.; Seferovic, P.; Senni, M.; Spera, F.R.; Stefanini, G.; Thiele, H.; Tomasoni, D.; Torracca, L.; Touyz, R.M.; Wilde, A.A.; Williams, B. & European Soc Cardiology (2022), ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic, Cardiovascular Research 118(7): 1618-1666.
- Baigent, C.; Windecker, S.; Andreini, D.; Arbelo, E.; Barbato, E.; Bartorelli, A.L.; Baumbach, A.; Behr, E.R.; Berti, S.; Bueno, H.; Capodanno, D.; Cappato, R.; Chieffo, A.; Collet, J.P.; Cuisset, T.; Simone, G. de; Delgado, V.; Dendale, P.; Dudek, D.; Edvardsen, T.; Elvan, A.; Gonzalez-Juanatey, J.R.; Gori, M.; Grobbee, D.; Guzik, T.J.; Halvorsen, S.; Haude, M.; Heidbuchel, H.; Hindricks, G.; Ibanez, B.; Karam, N.; Katus, H.; Klok, F.A.; Konstantinides, S.V.; Landmesser, U.; Leclercq, C.; Leonardi, S.; Lettino, M.; Marenzi, G.; Mauri, J.; Metra, M.; Morici, N.; Mueller, C.; Petronio, A.S.; Polovina, M.M.; Potpara, T.; Praz, F.; Prendergast, B.; Prescott, E.; Price, S.; Pruszczyk, P.; Rodriguez-Leor, O.; Roffi, M.; Romaguera, R.; Rosenkranz, S.; Sarkozy, A.; Scherrenberg, M.; Seferovic, P.; Senni, M.; Spera, F.R.; Stefanini, G.; Thiele, H.; Tomasoni, D.; Torracca, L.; Touyz, R.M.; Wilde, A.A.; Williams, B. & European Soc Cardiology (2022), ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up, European Heart Journal 43(11): 1059-1103.
- Gleditsch, J.; Jervan, O.; Haukeland-Parker, S.; Tavoly, M.; Geier, O.; Holst, R.; Klok, F.A.; Johannessen, H.H.; Ghanima, W. & Hopp, E. (2022), Effects of pulmonary rehabilitation on cardiac magnetic resonance parameters in patients with persistent dyspnea following pulmonary embolism, IJC HEART & VASCULATURE 40.
- Moss, J.L.; Klok, F.A.; Vo, U.G. & Richards, T. (2022), Controversies in the management of proximal deep vein thrombosis, Medical Journal of Australia 218(2).
- Valerio, L.; Mavromanoli, A.C.; Barco, S.; Abele, C.; Becker, D.; Bruch, L.; Ewert, R.; Faehling, M.; Fistera, D.; Gerhardt, F.; Ghofrani, H.A.; Grgic, A.; Grunig, E.; Halank, M.; Held, M.; Hobohm, L.; Hoeper, M.M.; Klok, F.A.; Lankeit, M.; Leuchte, H.H.; Martin, N.; Mayer, E.; Meyer, F.J.; Neurohr, C.; Opitz, C.; Schmidt, K.H.; Seyfarth, H.J.; Wachter, R.; Wilkens, H.; Wild, P.S.; Konstantinides, S.V.; Rosenkranz, S. & FOCUS Investigators (2022), Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism, European Heart Journal 43(36): 3387-3398.
- Sorensen, H.T.; Skajaa, N.; Klok, F.A.; Laugesen, K. & Farkas, D.K. (2022), Cancer risk in pulmonary hypertension patients, Clinical Epidemiology 14: 173-177.
- Overton, P.M.; Toshner, M.; Mulligan, C.; Vora, P.; Nikkho, S.; Backer, J. de; Lavon, B.; Klok, F.A. & PVRI Innovative Drug Dev Initiativ (2022), Pulmonary thromboembolic events in COVID-19-A systematic literature review, Pulmonary Circulation 12(3).
- Hojen, A.A.; Nielsen, P.B.; Overvad, T.F.; Albertsen, I.E.; Klok, F.A.; Rolving, N.; Sogaard, M. & Ording, A.G. (2022), Long-Term Management of Pulmonary Embolism: A Review of Consequences, Treatment, and Rehabilitation, Journal of Clinical Medicine 11(19).
- Ariens, R.A.; Hunt, B.J.; Agbani, E.O.; Ahnstrom, J.; Ahrends, R.; Alikhan, R.; Assinger, A.; Bagoly, Z.; Balduini, A.; Barbon, E.; Barrett, C.D.; Batty, P.; Carneiro, J.D.A.; Chan, W.S.; Maat, M. de; Wit, K. de; Denis, C.; Ellis, M.H.; Eslick, R.; Fu, H.X.; Hayward, C.P.M.; Ho-Tin-Noe, B.; Klok, F.A.; Kumar, R.; Leiderman, K.; Litvinov, R.I.; Mackman, N.; McQuilten, Z.; Neal, M.D.; Parker, W.A.E.; Preston, R.J.S.; Rayes, J.; Rezaie, A.R.; Roberts, L.N.; Rocca, B.; Shapiro, S.; Siegal, D.M.; Sousa, L.P.; Suzuki-Inoue, K.; Zafar, T. & Zhou, J.X. (2022), Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress, Research and Practice in Thrombosis and Haemostasis 6(5).
- Sadeghipour, P.; Talasaz, A.H.; Barco, S.; Bakhshandeh, H.; Rashidi, F.; Rafiee, F.; Rezaeifar, P.; Jamalkhani, S.; Matin, S.; Baghizadeh, E.; Tahamtan, O.; Sharif-Kashani, B.; Beigmohammadi, M.T.; Farrokhpour, M.; Sezavar, S.H.; Payandemehr, P.; Dabbagh, A.; Moghadam, K.G.; Jimenez, D.; Monreal, M.; Maleki, M.; Siegerink, B.; Spatz, E.S.; Piazza, G.; Parikh, S.A.; Kirtane, A.J.; Tassell, B.W. van; Lip, G.Y.H.; Goldhaber, S.Z.; Klok, F.A.; Krumholz, H.M.; Bikdeli, B. & Inspiration Investigators (2022), Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes, European Journal of Internal Medicine 103: 76-83.
- Gwozdz, A.M.; Jong, C.M.M. de; Fialho, L.S.; Likitabhorn, T.; Sossi, F.; Jaber, P.B.; Hojen, A.A.; Arcelus, J.I.; Auger, W.R.; Ay, C.; Barco, S.; Gazzana, M.B.; Bayley, J.; Bertoletti, L.; Cate-Hoek, A. ten; Cohen, A.T.; Connors, J.M.; Galanaud, J.P.; Labropoulos, N.; Langlois, N.; Meissner, M.H.; Noble, S.; Nossent, E.J.; Lovaton, P.P.D.; Robert-Ebadi, H.; Rosovsky, R.P.; Smolenaars, N.; Toshner, M.; Tromeur, C.; Wang, K.L.; Westerlund, E.; Wit, K. de; Black, S.A. & Klok, F.A. (2022), Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation, The Lancet Haematology 9(9): E698-E706.
- Haalen, F.M. van; Kaya, M.; Pelsma, I.C.M.; Dekkers, O.M.; Biermasz, N.R.; Cannegieter, S.C.; Huisman, M.V.; Vlijmen, B.J.M. van; Feelders, R.A.; Klok, F.A.; Pereira, A.M. & Endo-ERN Cushing Thrombosis study (2022), Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN), Orphanet Journal of Rare Diseases 17.
- Yamashita, Y.; Morimoto, T.; Klok, F.A.; Barco, S.; Nishimoto, Y.; Kato, T.; Ono, K.; Kimura, T. & COMMAND VTE Registry Investigators (2022), Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry, Journal of Thrombosis and Thrombolysis 54(3): 524-534.
- Cuker, A.; Tseng, E.K.; Nieuwlaat, R.; Angchaisuksiri, P.; Blair, C.; Dane, K.; DeSancho, M.T.; Diuguid, D.; Griffin, D.O.; Kahn, S.R.; Klok, F.A.; Lee, A.I.; Neumann, I.; Pai, A.; Righini, M.; Sanfilippo, K.M.; Siegal, D.M.; Skara, M.; Terrell, D.R.; Touri, K.; Akl, E.A.; Jabiri, R. al; Jabiri, Y. al; Barbara, A.M.; Bognanni, A.; Boulos, M.; Brignardello-Petersen, R.; Charide, R.; Colunga-Lozano, L.E.; Dearness, K.; Darzi, A.J.; Hussein, H.; Karam, S.G.; Mansour, R.; Morgano, G.P.; Morsi, R.Z.; Muti-Schunemann, G.; Nadim, M.K.; Philip, B.A.; Qiu, Y.; Benitez, Y.R.; Stevens, A.; Solo, K.; Wiercioch, W.; Mustafa, R.A. & Schunemann, H.J. (2022), American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19, Blood Advances 6(17): 4915-4923.
- Cuker, A.; Tseng, E.K.; Schunemann, H.J.; Angchaisuksiri, P.; Blair, C.; Dane, K.; DeSancho, M.T.; Diuguid, D.; Griffin, D.O.; Kahn, S.R.; Klok, F.A.; Lee, A.I.; Neumann, I.; Pai, A.; Righini, M.; Sanfilippo, K.M.; Siegal, D.M.; Skara, M.; Terrell, D.R.; Touri, K.; Akl, E.A.; Jabiri, R. al; Jabiri, Y. al; Boulos, M.; Brignardello-Petersen, R.; Charide, R.; Colunga-Lozano, L.E.; Dearness, K.; Darzi, A.J.; Karam, S.G.; Morgano, G.P.; Morsi, R.Z.; Philip, B.A.; Benitez, Y.R.; Stevens, A.; Solo, K.; Wiercioch, W.; Mustafa, R.A. & Nieuwlaat, R. (2022), American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19, Blood Advances 6(17): 4975-4982.
- Raaij, B.F.M. van; Stoger, J.L.; Hinnen, C.; Penfornis, K.M.; Jong, C.M.M. de; Klok, F.A.; Roukens, A.H.E.; Veldhuijzen, D.S.; Arbous, M.S.; Noordam, R.; Marges, E.R. & Geelhoed, J.J.M. (2022), Fibrotic-like abnormalities notably prevalent one year after hospitalization with COVID-19, RESPIRATORY MEDICINE AND RESEARCH 82.
- Klok, F.A.; Pai, M.; Huisman, M.V. & Makris, M. (2022), Vaccine-induced immune thrombotic thrombocytopenia, The Lancet Haematology 9(1): E73-E80.
- Munblit, D.; Nicholson, T.R.; Needham, D.M.; Seylanova, N.; Parr, C.; Chen, J.; Kokorina, A.; Sigfrid, L.; Buonsenso, D.; Bhatnagar, S.; Thiruvengadam, R.; Parker, A.M.; Preller, J.; Avdeev, S.; Klok, F.A.; Tong, A.L.; Diaz, J.V.; Groote, W. de; Schiess, N.; Akrami, A.; Simpson, F.; Olliaro, P.; Apfelbacher, C.; Rosa, R.G.; Chevinsky, J.R.; Saydah, S.; Schmitt, J.; Guekht, A.; Gorst, S.L.; Genuneit, J.; Reyes, L.F.; Asmanov, A.; O'Hara, M.E.; Scott, J.T.; Michelen, M.; Stavropoulou, C.; Warner, J.O.; Herridge, M. & Williamson, P.R. (2022), Studying the post-COVID-19 condition, BMC Medicine 20(1).
- Gleditsch, J.; Jervan, O.; Tavoly, M.; Geier, O.; Holst, R.; Klok, F.A.; Ghanima, W. & Hopp, E. (2022), Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism, IJC HEART & VASCULATURE 38.
- Geersing, G.J.; Takada, T.; Klok, F.A.; Büller, H.R.; Courtney, D.M.; Freund, Y.; Galipienzo, J.; Gal, G. le; Ghanima, W.; Kline, J.A.; Huisman, M.V.; Moons, K.G.M.; Perrier, A.; Parpia, S.; Robert-Ebadi, H.; Righini, M.; Roy, P.M.; Smeden, M. van; Stals, M.A.M.; Wells, P.S.; Wit, K. de; Kraaijpoel, N. & Es, N. van (2022), Ruling out pulmonary embolism across different healthcare settings: A systematic review and individual patient data meta-analysis, PLoS Medicine 19(1).
- Geersing, G.J.; Takada, T.; Klok, F.A.; Büller, H.R.; Courtney, D.M.; Freund, Y.; Galipienzo, J.; Gal, G. le; Ghanima, W.; Kline, J.A.; Huisman, M.V.; Moons, K.G.M.; Perrier, A.; Parpia, S.; Robert-Ebadi, H.; Righini, M.; Roy, P.M.; Smeden, M. van; Stals, M.A.M.; Wells, P.S.; Wit, K. de; Kraaijpoel, N. & Es, N. van (2022), Ruling out pulmonary embolism across different healthcare settings, PLoS Medicine.
- Gal, G. le; Kovacs, M.J.; Bertoletti, L.; Couturaud, F.; Dennie, C.; Hirsch, A.M.; Huisman, M.V.; Klok, F.A.; Kraaijpoel, N.; Mallick, R.; Pecarskie, A.; Pena, E.; Phillips, P.; Pichon, I.; Ramsay, T.; Righini, M.; Rodger, M.A.; Roy, P.M.; Sanchez, O.; Schmidt, J.; Schulman, S.; Shivakumar, S.; Trinh-Duc, A.; Verdet, R.; Vinsonneau, U.; Wells, P.; Wu, C.; Yeo, E.; Carrier, M. & SSPE Investigators (2022), Risk for recurrent venous thromboembolism in patients with subsegmental pulmonary embolism managed without anticoagulation, European Heart Journal 175(1).
- Schenker, C.; Marx, C.E.; Kraaijpoel, N.; Gal, G. le; Siegal, D.M.; Klok, F.A.; Aujesky, D. & Tritschler, T. (2022), Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review, Journal of Thrombosis and Haemostasis 21(6): 1553-1566.
- Dam, L. F. van; Boon, G.; Kroft, L. J. M.; Huisman, M. V. & Klok, F. A. (2021), Diagnostiek van een recidief veneuze trombo-embolie, Nederlands Tijdschrift voor Geneeskunde 165.
- Dronkers, C.E.A.; Hulle, T. van der; Gal, G. le; Kyrle, P.A.; Huisman, M.V.; Cannegieter, S.C. & Klok, F.A. (2021), Toward a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: Communication from the SSC of the ISTH.
- Chu, G.; Valerio, L.; Wall, S.J. van der; Barco, S.; Konstantinides, S.; Huisman, M.V. & Klok, F.A. (2021), Tailoring anticoagulant treatment of patients with atrial fibrillation using a novel bleeding risk score, Heart 107(7): 549-555.
- Giustozzi, M.; Valerio, L.; Agnelli, G.; Becattini, C.; Fronk, E.M.; Klok, F.A.; Konstantinides, S.V.; Vedovati, M.C.; Cohen, A.T. & Barco, S. (2021), Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE, European Journal of Internal Medicine 88: 43-51.
- Stals, M.A.M.; Grootenboers, M.J.J.H.; Guldener, C. van; Kaptein, F.H.J.; Braken, S.J.E.; Chen, Q.G.; Chu, G.; Driel, E.M. van; Sol, A.I. del; Jonge, E. de; Kant, K.M.; Pals, F.; Toorop, M.M.A.; Cannegieter, S.C.; Klok, F.A.; Huisman, M.V. & Dutch COVID Thrombosis Coalition (2021), Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients, Research and Practice in Thrombosis and Haemostasis 5(3): 412-420.
- Vaes, A.W.; Goertz, Y.M.J.; Herck, M. van; Machado, F.V.C.; Meys, R.; Delbressine, J.M.; Houben-Wilke, S.; Gaffron, S.; Maier, D.; Burtin, C.; Posthuma, R.; Loon, N.P.H. van; Franssen, F.M.E.; Hajian, B.; Simons, S.O.; , J.F.M. van boven; Klok, F.A.; Spaetgens, B.; Pinxt, C.M.H.; Liu, L.Y.L.; Wesseling, G.; Spies, Y.; Vijlbrief, H.; Hul, A.J.V.; Janssen, D.J.A. & Spruit, M.A. (2021), Recovery from COVID-19: a sprint or marathon?, ERJ Open Research 7(2).
- Valerio, L.; Barco, S.; Jankowski, M.; Rosenkranz, S.; Lankeit, M.; Held, M.; Gerhardt, F.; Bruch, L.; Ewert, R.; Faehling, M.; Freise, J.; Ghofrani, H.A.; Grunig, E.; Halank, M.; Hoeper, M.M.; Klok, F.A.; Leuchte, H.H.; Mayer, E.; Meyer, F.J.; Neurohr, C.; Opitz, C.; Schmidt, K.H.; Seyfarth, H.J.; Trudzinski, F.; Wachter, R.; Wilkens, H.; Wild, P.S. & Konstantinides, S.V. (2021), Quality of life 3 and 12 months following acute pulmonary embolism analysis from a prospective multicenter cohort study, Chest 159(6): 2428-2438.
- Haukeland-Parker, S.; Jervan, O.; Johannessen, H.H.; Gleditsch, J.; Stavem, K.; Steine, K.; Spruit, M.A.; Holst, R.; Tavoly, M.; Klok, F.A. & Ghanima, W. (2021), Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study), Trials 22(1).
- Kaptein, F.H.J.; Kroft, L.J.M.; Hammerschlag, G.; Ninaber, M.K.; Bauer, M.P.; Huisman, M.V. & Klok, F.A. (2021), Pulmonary infarction in acute pulmonary embolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 202: 162-169.
- Kaptein, F.H.J.; Stals, M.A.M.; Huisman, M.V. & Klok, F.A. (2021), Prophylaxis and treatment of COVID-19 related venous thromboembolism, POSTGRADUATE MEDICINE 133(Suppl 1).
- Boon, G.J.A.M.; Ende-Verhaar, Y.M.; Bavalia, R.; Bouazzaoui, L.H. el; Delcroix, M.; Dzikowska-Diduch, O.; Huisman, M.V.; Kurnicka, K.; Mairuhu, A.T.A.; Middeldorp, S.; Pruszczyk, P.; Ruigrok, D.; Verhamme, P.; Vliegen, H.W.; Noordegraaf, A.V.; Vriend, J.W.J.; Klok, F.A. & InShape II Study Grp (2021), Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Thorax 76(10): 1002-1009.
- Hendriks, S.V.; Hout, W.B. van den; Bemmel, T. van; Bistervels, I.M.; Eijsvogel, M.; Faber, L.M.; Hofstee, H.M.A.; Hulle, T. van der; Sol, A.I. del; Kruip, M.J.H.A.; Mairuhu, A.T.A.; Middeldorp, S.; Nijkeuter, M.; Huisman, M.V.; Klok, F.A. & YEARS Investigators (2021), Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands: A Cost Analysis, Thrombosis and Haemostasis.
- Asady, E.; Ghanima, W.; Jelsness-Jorgensen, L.P.; Klok, F.A.; Kahn, S.R.; Stromme, H. & Wik, H.S. (2021), Health-related quality-of-life questionnaires for deep vein thrombosis and pulmonary embolism: a systematic review on questionnaire development and methodology, Research and Practice in Thrombosis and Haemostasis 5(5).
- Barco, S.; Valerio, L.; Gallo, A.; Turatti, G.; Mahmoudpour, S.H.; Ageno, W.; Castellucci, L.A.; Cesarman-Maus, G.; Ddungu, H.; Paula, E.V. de; Dumantepe, M.; Goldhaber, S.Z.; Esposito, M.C.G.; Klok, F.A.; Kucher, N.; McLintock, C.; Ainle, F.N.; Simioni, P.; Spirk, D.; Spyropoulos, A.C.; Urano, T.; Zhai, Z.G.; Hunt, B.J. & Konstantinides, S.V. (2021), Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database, Research and Practice in Thrombosis and Haemostasis 5(5).
- Winter, M.A. de; Dorresteijn, J.A.N.; Ageno, W.; Ay, C.; Beyer-Westendorf, J.; Coppens, M.; Klok, F.A.; Moustafa, F.; Riva, N.; Artacho, P.C.R.; Vanassche, T. & Nijkeuter, M. (2021), Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score, Thrombosis and Haemostasis.
- Delcroix, M.; Torbicki, A.; Gopalan, D.; Sitbon, O.; Klok, F.A.; Lang, I.; Jenkins, D.; Kim, N.H.; Humbert, M.; Jais, X.; Noordegraaf, A.V.; Pepke-Zaba, J.; Brenot, P.; Dorfmuller, P.; Fadel, E.; Ghofrani, H.A.; Hoeper, M.M.; Jansa, P.; Madani, M.; Matsubara, H.; Ogo, T.; Grunig, E.; D'Armini, A.; Galie, N.; Meyer, B.; Corkery, P.; Meszaros, G.; Mayer, E. & Simonneau, G. (2021), ERS statement on chronic thromboembolic pulmonary hypertension, European Respiratory Journal 57(6).
- Boon, G.J.A.M.; Janssen, S.M.J.; Barco, S.; Bogaard, H.J.; Ghanima, W.; Kroft, L.J.M.; Meijboom, L.J.; Ninaber, M.K.; Nossent, E.J.; Spruit, M.A.; Symersky, P.; Vliegen, H.W.; Noordegraaf, A.V.; Huisman, M.V.; Siegerink, B.; Abbink, J.J. & Klok, F.A. (2021), Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE Syndrome, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 206: 66-75.
- Tieleman, R.G.; Klok, F.A.; Belfroid, E.; Hoogervorst-Schilp, J.; Schalkers, I.; Jansen, C.W. & Siebelink, H.J. (2021), Effect of anticoagulant therapy in COVID-19 patients, Netherlands Heart Journal 29(SUPPL 1): 35-44.
- Klok, F.A.; Toenges, G.; Mavromanoli, A.C.; Barco, S.; Ageno, W.; Bouvaist, H.; Brodmann, M.; Cuccia, C.; Couturaud, F.; Dellas, C.; Dimopoulos, K.; Duerschmied, D.; Empen, K.; Faggiano, P.; Ferrari, E.; Galie, N.; Galvani, M.; Ghuysen, A.; Giannakoulas, G.; Huisman, M.V.; Jimenez, D.; Kozak, M.; Lang, I.M.; Lankeit, M.; Meneveau, N.; Munzel, T.; Palazzini, M.; Petris, A.O.; Piovaccari, G.; Salvi, A.; Schellong, S.; Schmidt, K.H.; Verschuren, F.; Schmidtmann, I.; Meyer, G.; Konstantinides, S.V. & PEITHO-2 Investigators (2021), Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2) : a multinational, multicentre, single-arm, phase 4 trial, The Lancet Haematology 8(9): E627-E636.
- Wal, L.I. van der; Kroft, L.J.M.; Dam, L.F. van; Cobbaert, C.M.; Eikenboom, J.; Huisman, M.V.; Helmerhorst, H.J.F.; Klok, F.A.; Jonge, E. de & Dutch Covid Thrombosis Coalition (2021), Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: an observational cohort study.
- Gal, G. le; Carrier, M.; Castellucci, L.A.; Cuker, A.; Hansen, J.B.; Klok, F.A.; Langlois, N.J.; Levy, J.H.; Middeldorp, S.; Righini, M.; Walters, S. & ISTH CDE Task Force (2021), Development and implementation of common data elements for venous thromboembolism research, Journal of Thrombosis and Haemostasis 19(1): 297-303.
- Boon, G.J.A.M.; Huisman, M.V. & Klok, F.A. (2021), Determinants and Management of the Post-Pulmonary Embolism Syndrome, Seminars in Respiratory and Critical Care Medicine 42(02): 299-307.
- Dam, L.F. van; Dronkers, C.E.A.; Gautam, G.; Eckerbom, A.; Ghanima, W.; Gleditsch, J.; Haren, G.R. van; Heijne, A. von; Huisman, M.V.; Stoger, J.L.; Westerlund, E.; Kroft, L.J.M. & Klok, F.A. (2021), Detection of upper extremity deep vein thrombosis by magnetic resonance non-contrast thrombus imaging, Journal of Thrombosis and Haemostasis 19(8): 1973-1980.
- Barco, S. & Klok, F.A. (2021), D-dimer testing after anticoagulant discontinuation to predict recurrent venous thromboembolism, European Journal of Internal Medicine 89: 25-26.
- Dam, L.F. van; Hout, W.B. van den; Gautam, G.; Dronkers, C.E.A.; Ghanima, W.; Gleditsch, J.; Heijne, A. von; Hofstee, H.M.A.; Hovens, M.M.C.; Huisman, M.V.; Kolman, S.; Mairuhu, A.T.A.; Nijkeuter, M.; Ree, M.A. van de; Rooden, C.J. van; Westerbeek, R.E.; Westerink, J.; Westerlund, E.; Kroft, L.J.M. & Klok, F.A. (2021), Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis, Blood Advances 5(5): 1369-1378.
- Smit, J.M.; Matta, J.E.L.; Vink, R.; Muller, M.C.A.; Choi, K.F.; Baarle, F.E.H.P. van; Vlaar, A.P.J.; Klok, F.A.; Huisman, M.V.; Kraemer, C.V.E.; Girbes, A.R.J.; Westerloo, D.J. van & Tuinman, P.R. (2021), Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: a multicenter case-control study, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 200: 87-90.
- Machado, F.V.C.; Meys, R.; Delbressine, J.M.; Vaes, A.W.; Goertz, Y.M.J.; Herck, M. van; Houben-Wilke, S.; Boon, G.J.A.M.; Barco, S.; Burtin, C.; van't Hul, A.; Posthuma, R.; Franssen, F.M.E.; Spies, Y.; Vijlbrief, H.; Pitta, F.; Rezek, S.A.; Janssen, D.J.A.; Siegerink, B.; Klok, F.A. & Spruit, M.A. (2021), Construct validity of the post-COVID-19 functional status scale in adult subjects with COVID-19, Health and Quality of Life Outcomes 19(1).
- Dam, L.F. van; Kroft, L.J.M.; Boon, G.J.A.M.; Huisman, M.V.; Ninaber, M.K. & Klok, F.A. (2021), Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
- Stals, M.A.M.; Kaptein, F.H.J.; Kroft, L.J.M.; Klok, F.A. & Huisman, M.V. (2021), Challenges in the diagnostic approach of suspected pulmonary embolism in COVID-19 patients, POSTGRADUATE MEDICINE 133(Suppl 1): 36-41.
- Kapteijn, M.Y.; Kaptein, F.H.J.; Stals, M.A.M.; Duinen, S.G. van; Taphoorn, M.J.B.; Dirven, L.; Koekoek, J.A.F.; Klok, F.A.; Versteeg, H.H. & Buijs, J.T. (2021), CDKN2A MUTATIONAL STATUS IS ASSOCIATED WITH VENOUS THROMBOEMBOLISM IN PATIENTS WITH GLIOBLASTOMA, Neuro-Oncology 23: 20-21.
- Kruip, M.J.H.A.; Cannegieter, S.C.; Cate, H. ten; Gorp, E.C.M. van; Juffermans, N.P.; Klok, F.A.; Maas, C.; Vonk-Noordegraaf, A. & Dutch COVID Thrombosis Coalition S (2021), Caging the dragon, Research and Practice in Thrombosis and Haemostasis 5(2): 278-291.
- Boon, G.J.A.M.; Hout, W.B. van den; Barco, S.; Bogaard, H.J.; Delcroix, M.; Huisman, M.V.; Konstantinides, S.V.; Meijboom, L.J.; Nossent, E.J.; Symersky, P.; Noordegraaf, A.V. & Klok, F.A. (2021), A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension, ERJ Open Research 7(3).
- Barco, S.; Valerio, L.; Ageno, W.; Cohen, A.T.; Goldhaber, S.Z.; Hunt, B.J.; Iorio, A.; Jimenez, D.; Klok, F.A.; Kucher, N.; Mahmoudpour, S.H.; Middeldorp, S.; Munzel, T.; Tagalakis, V.; Wendelboe, A.M. & Konstantinides, S.V. (2021), Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18, The Lancet Respiratory Medicine 9(1): 33-42.
- Zielinski, G.D.; Rein, N. van; Teichert, M.; Klok, F.A.; Rosendaal, F.R.; Meer, F.J.M. van der; Huisman, M.V.; Cannegieter, S.C. & Lijfering, W.M. (2021), Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands, Pharmacoepidemiology & Drug Safety 30(8): 1027-1036.
- Hendriks, S.V.; Hout, W.B. van den; Bemmel, T. van; Bistervels, I.M.; Eijsvogel, M.; Faber, L.M.; Hofstee, H.M.A.; Hulle, T. van der; Sol, A.I. del; Kruip, M.J.H.A.; Mairuhu, A.T.A.; Middeldorp, S.; Nijkeuter, M.; Huisman, M.V.; Klok, F.A. & YEARS Investigators (2021), Home treatment compared to initial hospitalization in patients with acute pulmonary embolism in the Netherlands, Thrombosis and Haemostasis 122(3).
- Dam van F. Lisette , Kroft M. J. Lucia , Huisman V. Menno , Ninaber K. Maarten & Klok A. Frederikus (2021), Computed tomography pulmonary perfusion for prediction of short-term clinical outcome in acute pulmonary embolism, Thrombosis Haemostasis Open 5(1).
- Roy, P.M.; Penaloza, A.; Hugli, O.; Klok, F.A.; Arnoux, A.; Elias, A.; Couturaud, F.; Joly, L.M.; Lopez, R.; Faber, L.M.; Daoud-Elias, M.; Planquette, B.; Bokobza, J.; Viglino, D.; Schmidt, J.; Juchet, H.; Mahe, I.; Mulder, F.; Bartiaux, M.; Cren, R.; Moumneh, T.; Quere, I.; Falvo, N.; Montaclair, K.; Douillet, D.; Steinier, C.; Hendriks, S.V.; Benhamou, Y.; Szwebel, T.A.; Pernod, G.; Dublanchet, N.; Lapebie, F.X.; Javaud, N.; Ghuysen, A.; Sebbane, M.; Chatellier, G.; Meyer, G.; Jimenez, D.; Huisman, M.V.; Sanchez, O. & HOME-PE Study Grp (2021), Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria, European Heart Journal 42(33): 3146-+.
- Jervan, O.; Gleditsch, J.; Tavoly, M.; Klok, F.A.; Rashid, D.; Holst, R.; Steine, K.; Stavem, K. & Ghanima, W. (2021), Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 201: 90-99.
- Valerio, L.; Turatti, G.; Klok, F.A.; Konstantinides, S.V.; Kucher, N.; Roncon, L.; Zuin, M. & Barco, S. (2021), Prevalence of pulmonary embolism in 127 945 autopsies performed in cancer patients in the United States between 2003 and 2019.
- Mahe, I.; Agnelli, G.; Ay, C.; Bamias, A.; Becattini, C.; Carrier, M.; Chapelle, C.; Cohen, A.T.; Girard, P.; Huisman, M.V.; Klok, F.A.; Lopez-Nunez, J.J.; Maraveyas, A.; Mayeur, D.; Mir, O.; Monreal, M.; Righini, M.; Samama, C.M.; Syrigos, K.; Szmit, S.; Torbicki, A.; Verhamme, P.; Vicaut, E.; Wang, T.F.; Meyer, G. & Laporte, S. (2021), Extended anticoagulant treatment with full- or reduced-dose apixaban in patients with cancer-associated venous thromboembolism, Thrombosis and Haemostasis.
- Hamer, H.M.; Stroobants, A.K.; Bavalia, R.; Ponjee, G.A.E.; Klok, F.A.; Hulle, T. van der; Huisman, M.V.; Hendriks, H.A. & Middeldorp, S. (2021), Diagnostic accuracy of four different D-dimer assays, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 201: 18-22.
- Cuker, A.; Tseng, E.K.; Nieuwlaat, R.; Angchaisuksiri, P.; Blair, C.; Dane, K.; Davila, J.; DeSancho, M.T.; Diuguid, D.; Griffin, D.O.; Kahn, S.R.; Klok, F.A.; Lee, A.I.; Neumann, I.; Pai, A.; Righini, M.; Sanfilippo, K.M.; Siegal, D.; Skara, M.; Terrell, D.R.; Touri, K.; Akl, E.A.; Akl, I.B.; Bognanni, A.; Boulos, M.; Brignardello-Petersen, R.; Charide, R.; Chan, M.; Dearness, K.; Darzi, A.J.; Kolb, P.; Colunga-Lozano, L.E.; Mansour, R.; Morgano, G.P.; Morsi, R.Z.; Muti-Schunemann, G.; Noori, A.; Philip, B.A.; Piggott, T.; Qiu, Y.; Roldan, Y.; Schunemann, F.; Stevens, A.; Solo, K.; Wiercioch, W.; Mustafa, R.A. & Schunemann, H.J. (2021), American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19, Blood Advances 5(20): 3951-3959.
- Cuker, A.; Tseng, E.K.; Nieuwlaat, R.; Angchaisuksiri, P.; Blair, C.; Dane, K.; Davila, J.; DeSancho, M.T.; Diuguid, D.; Griffin, D.O.; Kahn, S.R.; Klok, F.A.; Lee, A.I.; Neumann, I.; Pai, A.; Pai, M.; Righini, M.; Sanfilippo, K.M.; Siegal, D.; Skara, M.; Touri, K.; Akl, E.A.; Akl, I.B.; Boulos, M.; Brignardello-Petersen, R.; Charide, R.; Chan, M.; Dearness, K.; Darzi, A.J.; Kolb, P.; Colunga-Lozano, L.E.; Mansour, R.; Morgano, G.P.; Morsi, R.Z.; Noori, A.; Piggott, T.; Qiu, Y.; Roldan, Y.; Schunemann, F.; Stevens, A.; Solo, K.; Ventresca, M.; Wiercioch, W.; Mustafa, R.A. & Schunemann, H.J. (2021), American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19, Blood Advances 5(3): 872-888.
- Stals, M.A.M.; Takada, T.; Kraaijpoel, N.; Es, N. van; Buller, H.R.; Courtney, D.M.; Freund, Y.; Galipienzo, J.; Gal, G. le; Ghanima, W.; Huisman, M.V.; Kline, J.A.; Moons, K.G.M.; Parpia, S.; Perrier, A.; Righini, M.; Robert-Ebadi, H.; Roy, P.M.; Smeden, M. van; Wells, P.S.; Wit, K. de; Geersing, G.J. & Klok, F.A. (2021), Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups A Systematic Review and Individual-Patient Data Meta-analysis, Annals of Internal Medicine.
- Gal, G. le; Kovacs, M.J.; Bertoletti, L.; Couturaud, F.; Dennie, C.; Hirsch, A.M.; Huisman, M.V.; Klok, F.A.; Kraaijpoel, N.; Mallick, R.; Pecarskie, A.; Pena, E.; Phillips, P.; Pichon, I.; Ramsay, T.; Righini, M.; Rodger, M.A.; Roy, P.M.; Sanchez, O.; Schmidt, J.; Schulman, S.; Shivakumar, S.; Trinh-Duc, A.; Verdet, R.; Vinsonneau, U.; Wells, P.; Wu, C.; Yeo, E.; Carrier, M. & SSPE Investigators (2021), Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation A Multicenter Prospective Cohort Study, Annals of Internal Medicine.
- Boon, G.J.A.M.; Ende-Verhaar, Y.M.; Beenen, L.F.M.; Coolen, J.; Delcroix, M.; Golebiowski, M.; Huisman, M.V.; Mairuhu, A.T.A.; Meijboom, L.J.; Middeldorp, S.; Pruszczyk, P.; Rooden, C.J. van; Noordegraaf, A.V.; Kroft, L.J.M. & Klok, F.A. (2021), Prediction of chronic thromboembolic pulmonary hypertension with standardised evaluation of initial computed tomography pulmonary angiography performed for suspected acute pulmonary embolism, European Radiology 32.
- Hanna-Sawires, R.G.; Groen, J.V.; Hamming, A.; Tollenaar, R.A.E.M.; Mesker, W.E.; Luelmo, S.A.C.; Vahrmeijer, A.L.; Bonsing, B.A.; Versteeg, H.H.; Klok, F.A. & Mieog, J.S.D. (2021), Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 207: 134-139.
- Boon, G.J.A.M.; Jairam, P.M.; Groot, G.M.C.; Rooden, C.J. van; Ende-Verhaar, Y.M.; Beenen, L.F.M.; Kroft, L.J.M.; Bogaard, H.J.; Huisman, M.V.; Symersky, P.; Noordegraaf, A.V.; Meijboom, L.J. & Klok, F.A. (2021), Identification of chronic thromboembolic pulmonary hypertension on CTPAs performed for diagnosing acute pulmonary embolism depending on level of expertise, European Journal of Internal Medicine 93: 64-70.
- Braams, N.J.; Boon, G.J.A.M.; Man, F.S. de; Es, J. van; Exter, P.L. den; Kroft, L.J.M.; Beenen, L.F.M.; Huisman, M.V.; Nossent, E.J.; Boonstra, A.; Noordegraaf, A.V.; Ruigrok, D.; Klok, F.A.; Bogaard, H.J. & Meijboom, L.J. (2021), Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension, European Respiratory Journal 58(6).
- Perrot, M. de; Gopalan, D.; Jenkins, D.; Lang, I.M.; Fadel, E.; Delcroix, M.; Benza, R.; Heresi, G.A.; Kanwar, M.; Granton, J.T.; McInnis, M.; Klok, F.A.; Kerr, K.M.; Pepke-Zaba, J.; Toshner, M.; Bykova, A.; Armini, A.M. d'; Robbins, I.M.; Madani, M.; McGiffin, D.; Wiedenroth, C.B.; Mafeld, S.; Opitz, I.; Mercier, O.; Uber, P.A.; Frantz, R.P. & Auger, W.R. (2021), Evaluation and management of patients with chronic thromboembolic pulmonary hypertension, Journal of Heart and Lung Transplantation 40(11): 1301-1326.
- Kaptein, F.H.J.; Stals, M.A M.; Grootenboers, M.; Braken, S.J.E.; Burggraaf, J.L.I.; Bussel, B.C.T. van; Cannegieter, S.C.; Cate, H. ten; Endeman, H.; Gommers, D.A.M.P.J.; Guldener, C. van; Jonge, E. de; Juffermans, N.P.; Kant, K.M.; Kevenaar, M.E.; Koster, S.; Kroft, L.J.M.; Kruip, M.J. H. A.; Leentjens, J.; Marechal, C.; Soei, Y.L.; Tjepkema, L.; Visser, C.; Klok, F.A. & Huisman, M.V. (2021), Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave, Thrombosis research 199.
- Klok, F.A. & Huisman, M.V. (2020), When I treat a patient with acute pulmonary embolism at home, Hematology: 190-194.
- Barco, S.; Klok, F.A.; Konstantinides, S.V.; Dartevelle, P.; Fadel, E.; Jenkins, D.; Kim, N.H.; Madani, M.; Matsubara, H.; Mayer, E.; Pepke-Zaba, J.; Simonneau, G.; Delcroix, M. & Lang, I.M. (2020), Sex-specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry, Journal of Thrombosis and Haemostasis 18(1): 151-161.
- Walter Ageno, Sarwa Darwish Murad, Mandy N. Lauw, Antonio Iglesias del Sol & Ysbrand Willink (2020), Magnetic resonance thrombus imaging to differentiate acute from chronic portal vein thrombosis, Thrombosis Haemostasis Open 04(03).
- Lisette F van Dam 1, Lucia Jm Kroft 2, Charlotte Ea Dronkers 1, Jan van Schaik 3, Guido R van Haren 2, Menno V Huisman 1 & Frederikus A Klok 1 (2020), Magnetic Resonance Direct Thrombus Imaging (MRDTI) can distinguish between old and new thrombosis in the abdominal aorta.
- Boon, G.J.A.M.; Barco, S.; Bertoletti, L.; Ghanima, W.; Huisman, M.V.; Kahn, S.R.; Noble, S.; Prandoni, P.; Rosovsky, R.P.; Sista, A.K.; Siegerink, B. & Klok, F.A. (2020), Measuring functional limitations after venous thromboembolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 190: 45-51.
- Zielinski, G.D.; Rein, N. van; Teichert, M.; Klok, F.A.; Rosendaal, F.R.; Meer, F.J.M. van der; Huisman, M.V.; Cannegieter, S.C. & Lijfering, W.M. (2020), Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands, Research and Practice in Thrombosis and Haemostasis 4(1): 141-153.
- Dam, L.F. van; Dronkers, C.E.A.; Gautam, G.; Eckerbom, A.; Ghanima, W.; Gleditsch, J.; Heijne, A. von; Hofstee, H.M.A.; Hovens, M.M.C.; Huisman, M.V.; Kolman, S.; Mairuhu, A.T.A.; Nijkeuter, M.; Ree, M.A. van de; Rooden, C.J. van; Westerbeek, R.E.; Westerink, J.; Westerlund, E.; Kroft, L.J.M.; Klok, F.A. & Theia Study Grp (2020), Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis, Blood 135(16): 1377-1385.
- Exter, P.L. den; Beeres, S.L.M.A.; Eikenboom, J.; Klok, F.A. & Huisman, M.V. (2020), Anticoagulant treatment and bleeding complications in patients with left ventricular assist devices, Expert Review of Cardiovascular Therapy 18(6): 363-372.
- Boon, G.J.A.M.; Huisman, M.V. & Klok, F.A. (2020), Why, Whom, and How to Screen for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism, Seminars in Thrombosis and Hemostasis.
- Klok, F.A.; Kruip, M.J.H.A.; Meer, N.J.M. van der; Arbous, M.S.; Gommers, D.A.M.P.J.; Kant, K.M.; Kaptein, F.H.J.; Paassen, J. van; Stals, M.A.M.; Huisman, M.V. & Endeman, H. (2020), Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 191: 145-147.
- Dam, L.F. van; Kroft, L.J.M.; Wal, L.I. van der; Cannegieter, S.C.; Eikenboom, J.; Jonge, E. de; Huisman, M.V. & Klok, F.A. (2020), More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
- Nopp, S.; Klok, F.A.; Moik, F.; Petrovic, M.; Derka, I.; Ay, C. & Zwick, R.H. (2020), Outpatient pulmonary rehabilitation in patients with persisting symptoms after pulmonary embolism, Journal of Clinical Medicine 9(6).
- Hamulyak, E.N.; Wiegers, H.M.G.; Scheres, L.J.J.; Hutten, B.A.; Lange, M.E.; Timmermans, A.; Westerweel, P.E.; Nijziel, M.R.; Kruip, M.J.H.A.; Wolde, M. ten; Ypma, P.F.; Klok, F.A.; Nieuwenhuizen, L.; Wissen, S.; Hovens, M.M.C.; Faber, L.M.; Kamphuisen, P.W.; Buller, H.R. & Middeldorp, S. (2020), Heavy menstrual bleeding on direct factor Xa inhibitors, Research and Practice in Thrombosis and Haemostasis 5(1).
- Hobohm, L.; Keller, K.; Valerio, L.; Ainle, F.N.; Klok, F.A.; Munzel, T.; Kucher, N.; Lankeit, M.; Konstantinides, S.V. & Barco, S. (2020), Fatality rates and use of systemic thrombolysis in pregnant women with pulmonary embolism, ESC Heart Failure 7(5): 2365-2372.
- Klok, F.A. & Huisman, M.V. (2020), How I assess and manage the risk of bleeding in patients treated for venous thromboembolism, Blood 135(10): 724-734.
- Gautam, G.; Sebastian, T. & Klok, F.A. (2020), How to differentiate recurrent deep vein thrombosis from postthrombotic syndrome, Hämostaseologie 40(03): 280-290.
- Exter, P.L. den; Kroft, L.J.M.; Gonsalves, C.; Gal, G. le; Schaefer-Prokop, C.M.; Carrier, M.; Huisman, M.V. & Klok, F.A. (2020), Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism, Research and Practice in Thrombosis and Haemostasis 4(8): 1251-1261.
- Boon, G.J.A.M.; Bogaard, H.J. & Klok, F.A. (2020), Essential aspects of the follow-up after acute pulmonary embolism: an illustrated review, Research and Practice in Thrombosis and Haemostasis 4(6): 958-968.
- Klok, F.A. & Barco, S. (2020), Anticoagulation in splanchnic and cerebral vein thrombosis: still groping in the dark, Research and Practice in Thrombosis and Haemostasis 4(7): 1080-1082.
- Dam, L.F. van; Kroft, L.J.M.; Wal, L.I. van der; Cannegieter, S.C.; Eikenboom, J.; Jonge, E. de; Huisman, M.V. & Klok, F.A. (2020), Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 193: 86-89.
- Braams, N.J.; Ruigrok, D.; Schokker, M.G.M.; Padervinskiene, L.; Man, F.S. de; Marcus, J.T.; Lely, R.J.; Beijk, M.A.M.; Klok, F.A.; Huisman, M.V.; Nossent, E.J.; Noordegraaf, A.V.; Symersky, P.; Bogaard, H.J. & Meijboom, L.J. (2020), Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension, Journal of Heart and Lung Transplantation 39(3): 248-256.
- Klok, F.A.; Kruip, M.J.H.A.; Meer, N.J.M. van der; Arbous, M.S.; Gommers, D.; Kant, K.M.; Kaptein, F.H.J.; Paassen, J. van; Stals, M.A.M.; Huisman, M.V. & Endeman, H. (2020), Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 191: 148-150.
- Dam, L.F. van; Dronkers, C.E.A.; Gautam, G.; Eckerbom, A.; Ghanima, W.; Gleditsch, J.; Heijne, A. von; Hofstee, H.M.A.; Hovens, M.M.C.; Huisman, M.V.; Kolman, S.; Mairuhu, A.T.A.; Nijkeuter, M.; Ree, M.A. van de; Rooden, C.J. van; Westerbeek, R.E.; Westerink, J.; Westerlund, E.; Kroft, L.J.M.; Klok, F.A. & Theia Study Grp (2020), Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis.
- Ruigrok, D.; Braams, N.J.; Nossent, E.J.; Bonta, P.I.; Boonstra, A.; Lely, R.J.; Klok, F.A.; Noordegraaf, A.V.; Symersky, P.; Bogaard, H.J. & Meijboom, L.J. (2020), Dynamic vascular changes in chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy, Pulmonary Circulation 10(4).
- Cannegieter, S.C. & Klok, F.A. (2020), COVID-19 associated coagulopathy and thromboembolic disease: commentary on an interim expert guidance, Research and Practice in Thrombosis and Haemostasis 4(4): 439-445.
- Lorenz, G.; Saeedan, M. bin; Bullen, J.; Klok, F.A.; Kroft, L.J.M.; Meijboom, L.J.; Heresi, G.A.; Sripariwuth, A. & Renapurkar, R.D. (2020), CT-Based Biomarkers for Prediction of Chronic Thromboembolic Pulmonary Hypertension After an Acute Pulmonary Embolic Event, American Journal of Roentgenology 215(4): 800-806.
- Boon, G.J.A.M.; Rein, N. van; Bogaard, H.J.; Ende-Verhaar, Y.M.; Huisman, M.V.; Kroft, L.J.M.; Meer, F.J.M. van der; Meijboom, L.J.; Symersky, P.; Noordegraaf, A.V. & Klok, F.A. (2020), Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism, PLoS ONE 15(4).
- Hendriks, S.V.; Bavalia, R.; Bemmel, T. van; Bistervels, I.M.; Eijsvogel, M.; Faber, L.M.; Fogteloo, J.; Hofstee, H.M.A.; Hulle, T. van der; Sol, A.I. del; Kruip, M.J.H.A.; Mairuhu, A.T.A.; Middeldorp, S.; Nijkeuter, M.; Huisman, M.V.; Klok, F.A. & YEARS Investigators (2020), Current practice patterns of outpatient management of acute pulmonary embolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 193: 60-65.
- Giustozzi, M.; Agnelli, G.; Toro-Cervera, J. del; Klok, F.A.; Rosovsky, R.P.; Martin, A.C.; Herold, J.; Tzoran, I.; Szmit, S.; Bertoletti, L.; Becattini, C. & Huisman, M.V. (2020), Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis, Thrombosis and Haemostasis 120(07): 1128-1136.
- Hendriks, S.V.; Exter, P.L. den; Zondag, W.; Brouwer, R.; Eijsvogel, M.; Grootenboers, M.J.; Faber, L.M.; Heller-Baan, R.; Hofstee, H.M.A.; Sol, A.I. del; Kruip, M.J.H.A.; Mairuhu, A.T.A.; Melissant, C.F.; Peltenburg, H.G.; Ree, M.A. van de; Serne, E.H.; Huisman, M.V.; Klok, F.A. & Hestia Vesta Investigators (2020), Reasons for Hospitalization of Patients with Acute Pulmonary Embolism Based on the Hestia Decision Rule, Thrombosis and Haemostasis 120(08): 1217-1220.
- Braams, N.J.; Boon, G.J.A.M.; Exter, P.L. den; Kroft, L.J.M.; Beenen, L.F.M.; Huisman, M.V.; Noordegraaf, A.V.; Bogaard, H.J.; Man, F.S. de; Klok, F.A. & Meijboom, L.J. (2020), Differential effect of anticoagulant treatment on vascular morphology in patients with acute pulmonary embolism, European Heart Journal 41: 2270-2270.
- Hendriks, S.V.; Klok, F.A.; Exter, P.L. den; Eijsvogel, M.; Faber, L.M.; Hofstee, H.M.A.; Sol, A.I. del; Kroft, L.J.M.; Mairuhu, A.T.A.; Huisman, M.V. & Hestia Vesta Investigators (2020), Right Ventricle-to-Left Ventricle Diameter Ratio Measurement Seems to Have No Role in Low-Risk Patients with Pulmonary Embolism Treated at Home Triaged by Hestia Criteria.
- Fronas, S.G.; Dahm, A.E.A.; Wik, H.S.; Jorgensen, C.T.; Gleditsch, J.; Raouf, N.; Holst, R.; Klok, F.A. & Ghanima, W. (2020), Safety and feasibility of rivaroxaban in deferred workup of patients with suspected deep vein thrombosis, Blood Advances 4(11): 2468-2476.
- Fronas, S.G.; Jorgensen, C.T.; Dahm, A.E.A.; Wik, H.S.; Gleditsch, J.; Raouf, N.; Holst, R.; Klok, F.A. & Ghanima, W. (2020), Safety of a strategy combining D-dimer testing and whole-leg ultrasonography to rule out deep vein thrombosis, Blood Advances 4(20): 5002-5010.
- Chu, G.; Seelig, J.; Trinks-Roerdink, E.M.; Alem, A.P. van; Alings, M.; Bemt, B. van den; Boersma, L.V.A.; Brouwer, M.A.; Cannegieter, S.C.; Cate, H. ten; Kirchhof, C.J.H.J.; Crijns, H.J.G.M.; Dijk, E.J. van; Elvan, A.; Gelder, I.C. van; Groot, J.R. de; Hartog, F.R. den; Jong, J.S.S.G. de; Jong, S. de; Klok, F.A.; Lenderink, T.; Luermans, J.G.; Meeder, J.G.; Pisters, R.; Polak, P.; Rienstra, M.; Smeets, F.; Tahapary, G.J.M.; Theunissen, L.; Tieleman, R.G.; Trines, S.A.; Voort, P. van der; Geersing, G.J.; Rutten, F.H.; Hemels, M.E. & Huisman, M.V. (2020), Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation, BMJ Open 10(8).
- Stals, M.A.M.; Klok, F.A. & Huisman, M.V. (2020), Diagnostic management of acute pulmonary embolism in special populations, Expert Review of Respiratory Medicine 14(7): 729-736.
- Meijer, F.M.M.; Hendriks, S.V.; Huisman, M.V.; Hulle, T. van der; Swenne, C.A.; Kies, P.; Jongbloed, M.R.M.; Egorova, A.D.; Vliegen, H.W. & Klok, F.A. (2020), Lack of diagnostic utility of the ECG-derived ventricular gradient in patients with suspected acute pulmonary embolism, Journal of Electrocardiology 61: 141-146.
- Klok, F.A.; Couturaud, F.; Delcroix, M. & Humbert, M. (2020), Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, European Respiratory Journal 55(6).
- Dam, L.F. van; Gautam, G.; Dronkers, C.E.A.; Ghanima, W.; Gleditsch, J.; Heijne, A. von; Hofstee, H.M.A.; Hovens, M.M.C.; Huisman, M.V.; Kolman, S.; Mairuhu, A.T.A.; Nijkeuter, M.; Ree, M.A. van de; Rooden, C.J. van; Westerbeek, R.E.; Westerink, J.; Westerlund, E.; Kroft, L.J.M. & Klok, F.A. (2020), Safety of using the combination of the Wells rule and D-dimer test for excluding acute recurrent ipsilateral deep vein thrombosis, Journal of Thrombosis and Haemostasis 18(9): 2341-2348.
- Dam, L.F. van; Walderveen, M.A.A. van; Kroft, L.J.M.; Kruyt, N.D.; Wermer, M.J.H.; Osch, M.J.P. van; Huisman, M.V. & Klok, F.A. (2020), Current imaging modalities for diagnosing cerebral vein thrombosis - a critical review, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 189.
- Es, J. van; Cheung, Y.W.; Es, N. van; Klok, F.A.; Dronkers, C.E.A.; Wolde, M. ten; Kruip, M.J.H.A.; Huisman, M.V.; Meijer, K.; Kamphuisen, P.W.; Gerdes, V.E.A. & Middeldorp, S. (2020), Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 187: 125-130.
- Klok, F.A.; Boon, G.J.A.M.; Barco, S.; Endres, M.; Geelhoed, J.J.M.; Knauss, S.; Rezek, S.A.; Spruit, M.A.; Vehreschild, J. & Siegerink, B. (2020), The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19.
- Klok, E.; Boon, G.J.A.M.; Ende-Verhaar, Y.M.; Bavalia, R.; Delcroix, M.; Dzikowska-Diduch, O.; Kurnicka, K.; Mairuhu, A.T.A.; Middeldorp, S.; Pruszczyk, P.; Ruigrol, D.; Verhamme, P.; Vliegen, H.; Noordegraaf, A.V.; Huisman, M.V. & InShape II Investigators (2020), Accurate and efficient non-invasive strategy for early identification of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism (InShape II study), European Heart Journal 41: 2273-2273.
- d'Alessandro, E.; Becker, C.; Bergmeier, W.; Bode, C.; Bourne, J.H.; Brown, H.; Buller, H.R.; Cate-Hoek, A.J. ten; Cate, V. ten; Cauteren, Y.J.M. van; Cheung, Y.F.H.; Cleuren, A.; Coenen, D.; Crijns, H.J.G.M.; Simone, I. de; Dolleman, S.C.; Klein, C.E.; Fernandez, D.I.; Granneman, L.; Hof, A.T. van t; Henke, P.; Henskens, Y.M.C.; Huang, J.N.; Jennings, L.K.; Jooss, N.; Karel, M.; Kerkhof, D. van den; Klok, F.A.; Kremers, B.; Lammle, B.; Leader, A.; Lundstrom, A.; Mackman, N.; Mannucci, P.M.; Maqsood, Z.; Meijden, P.E.J. van der; Moorsel, M. van; Moran, L.A.; Morser, J.; Mourik, M. van; Navarro, S.; Neagoe, R.A.I.; Olie, R.H.; Paridon, P. van; Posma, J.; Provenzale, I.; Reitsma, P.H.; Scaf, B.; Schurgers, L.; Seelig, J.; Siegbahn, A.; Siegerink, B.; Soehnlein, O.; Soriano, E.M.; Sowa, M.A.; Spronk, H.M.H.; Storey, R.F.; Tantiwong, C.; Veninga, A.; Wang, X.Q.; Watson, S.P.; Weitz, J.; Zeerleder, S.S.; Cate, H. ten; Lina, B.; Christoph, B.; Marc, H.; Peter, K.; GregoryLip, K.R.; Steffen, M.; Philipp, V.; Christian, W.; Johann, W. & Sci Reviewer Comm (2020), Thrombo-inflammation in cardiovascular disease, Thrombosis and Haemostasis 120(4): 538-564.
- Barco, S.; Mahmoudpour, S.H.; Valerio, L.; Klok, F.A.; Munzel, T.; Middeldorp, S.; Ageno, W.; Cohen, A.T.; Hunt, B.J. & Konstantinides, S.V. (2020), Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database, The Lancet Respiratory Medicine 8(3): 277-287.
- Hendriks, S.V.; Lankeit, M.; Exter, P.L. den; Zondag, W.; Brouwer, R.; Eijsvogel, M.; Grootenboers, M.J.; Faber, L.M.; Heller-Baan, R.; Hofstee, H.M.A.; Sol, A.I. del; Mairuhu, A.T.A.; Melissant, C.F.; Peltenburg, H.G.; deRee, M.A. van; Serne, E.H.; Konstantinides, S.; Klok, F.A.; Huisman, M.V. & Vesta Investigators (2020), Uncertain value of high-sensitive troponin T for selecting patients with acute pulmonary embolism for outpatient treatment by hestia criteria.
- Gangaraju, R. & Klok, F.A. (2020), Advanced therapies and extracorporeal membrane oxygenation for the management of high-risk pulmonary embolism, Hematology: 195-200.
- Klok, F. A.; Kroft, L. J. M. & Huisman, M. V. (2020), Acute subsegmentele longembolie, Nederlands Tijdschrift voor Geneeskunde 164.
- Klok, F. A.; Exter, P. L. den; Huisman, M. V. & Eikenboom, J. (2020), Do’s-and-don’ts bij COVID-19-coagulopathie, Nederlands Tijdschrift voor Geneeskunde 164.
- Barco, S.; Mahmoudpour, S.H.; Valerio, L.; Klok, F.A.; Munzel, T.; Middeldorp, S.; Ageno, W.; Cohen, A.T.; Hunt, B.J. & Konstantinides, S.V. (2020), Trends in mortality related to pulmonary embolism in the European Region, 2000–15, The Lancet Respiratory Medicine 8(3): 277-287.
- Boon, G.J.A.M.; Bogaard, H.J. & Klok, F.A. (2020), Essential aspects of the follow‐up after acute pulmonary embolism, Research and Practice in Thrombosis and Haemostasis 4(6): 958--968.
- Boon, G.J.A.M.; Rein, N. van; Bogaard, H.J.; Ende-Verhaar, Y.M.; Huisman, M.V.; Kroft, L.J.M.; Meer, F.J.M. van der; Meijboom, L.J.; Symersky, P.; Noordegraaf, A.V. & Klok, F.A. (2020), Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism (vol 15, e0232354, 2020), PLoS ONE 15(6).
- Baumgartner, C.; Klok, F.A.; Carrier, M.; Limacher, A.; Moor, J.; Righini, M.; Beer, J.H.; Peluso, M.; Rakovic, D.; Huisman, M.V. & Aujesky, D. (2020), Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: protocol for a multicentre randomised placebo-controlled non-inferiority trial (SAFE-SSPE), BMJ Open 10(11).
- Tromeur, C.; Pol, L.M. van der; Roux, P.Y. le; Ende-Verhaar, Y.; Salaun, P.Y.; Leroyer, C.; Couturaud, F.; Kroft, L.J.M.; Huisman, M.V. & Klok, F.A. (2019), Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a systematic review and meta-analysis, Haematologica 104(1): 176-188.
- Keller, K.; Tesche, C.; Gerhold-Ay, A.; Nickels, S.; Klok, F.A.; Rappold, L.; Hasenfuss, G.; Dellas, C.; Konstantinides, S.V. & Lankeit, M. (2019), Quality of life and functional limitations after pulmonary embolism and its prognostic relevance, Journal of Thrombosis and Haemostasis 17(11): 1923-1934.
- Ende-Verhaar, Y.M.; Meijboom, L.J.; Kroft, L.J.M.; Beenen, L.F.M.; Boon, G.J.A.M.; Middeldorp, S.; Nossent, E.J.; Symersky, P.; Huisman, M.V.; Bogaard, H.J.; Noordegraaf, A.V. & Klok, F.A. (2019), Usefulness of standard computed tomography pulmonary angiography performed for acute pulmonary embolism for identification of chronic thromboembolic pulmonary hypertension: results of the InShape III study, Journal of Heart and Lung Transplantation 38(7): 731-738.
- Swan, D.; Hitchen, S.; Klok, F.A. & Thachil, J. (2019), The problem of under-diagnosis and over-diagnosis of pulmonary embolism, Thrombosis Research 177: 122-129.
- Klok, F.A. (2019), Know your history, Thrombosis Research 182: 192-193.
- Wall, S.J. van der; Lopes, R.D.; Aisenberg, J.; Reilly, P.; Ryn, J. van; Glund, S.; Elsaesser, A.; Klok, F.A.; Pollack, C.V. & Huisman, M.V. (2019), Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding, Circulation 139(6): 748-756.
- Pol, L.M. van der; Tromeur, C.; Bistervels, I.M.; Ni Ainle, F.; Bemmel, T. van; Bertoletti, L.; Couturaud, F.; Dooren, Y.P.A. van; Elias, A.; Faber, L.M.; Hofstee, H.M.A.; Hulle, T. van der; Kruip, M.J.H.A.; Maignan, M.; Mairuhu, A.T.A.; Middeldorp, S.; Nijkeuter, M.; Roy, P.M.; Sanchez, O.; Schmidt, J.; Wolde, M. ten; Klok, F.A.; Huisman, M.V. & Artemis Study Investigators (2019), Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism, New England Journal of Medicine 380(12): 1139-1149.
- Hendriks, S.V.; Huisman, M.V.; Eikenboom, J.C.J.; Fogteloo, J.; Gelderblom, H.; Meer, F.J.M. van der; Stenger, W.J.E.; Verschoor, A.J.; Versteeg, H.H. & Klok, F.A. (2019), Home treatment of patients with cancer-associated venous thromboembolism - An evaluation of daily practice, Thrombosis Research 184: 122-128.
- Klok, F.A. & Barco, S. (2019), Optimal management of hormonal contraceptives after an episode of venous thromboembolism, Thrombosis Research 181: S1-S5.
- Hanna-Sawires, R.G.; Groen, J.V.; Klok, F.A.; Tollenaar, R.A.E.M.; Mesker, W.E.; Swijnenburg, R.J.; Vahrmeijer, A.L.; Bonsing, B.A. & Mieog, J.S.D. (2019), Outcomes following pancreatic surgery using three different thromboprophylaxis regimens, British Journal of Surgery 106(6): 765-773.
- Ende-Verhaar, Y.M.; Tick, L.W.; Klok, F.A.; Huisman, M.V.; Rosendaal, F.R.; Cessie, S. le & Cannegieter, S.C. (2019), Post-thrombotic syndrome: Short and long-term incidence and risk factors, Thrombosis Research 177: 102-109.
- Barco, S.; Russo, M.; Vicaut, E.; Becattini, C.; Bertoletti, L.; Beyer-Westendorf, J.; Bouvaist, H.; Couturaud, F.; Danays, T.; Dellas, C.; Duerschmied, D.; Empen, K.; Ferrari, E.; Galie, N.; Jimenez, D.; Klok, F.A.; Kostrubiec, M.; Kozak, M.; Kupatt, C.; Lang, I.M.; Lankeit, M.; Meneveau, N.; Palazzini, M.; Pruszczyk, P.; Rugolotto, M.; Salvi, A.; Sanchez, O.; Schellong, S.; Sobkowicz, B.; Meyer, G. & Konstantinides, S.V. (2019), Incomplete echocardiographic recovery at 6months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial, Clinical Research in Cardiology 108(7): 772-778.
- Klok, F.A.; Versteeg, H.H.; Verschoor, A.J. & Huisman, M.V. (2019), Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis', British Journal of Cancer 120(4): 472-472.
- Tromeur, C.; Pol, L.M. van der; Roux, P.Y. le; Ende-Verhaar, Y.; Salaun, P.Y.; Leroyer, C.; Couturaud, F.; Kroft, L.J.M.; Huisman, M.V. & Klok, F.A. (2019), Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a systematic review and meta-analysis, Haematologica 104(1): 176-188.
- Wall, S.J. van der; Rein, N. van; Bemt, B. van den; Kruip, M.J.H.A.; Meijer, K.; Boome, L.C.J. te; Simmers, T.A.; Alings, A.M.W.; Tieleman, R.; Westerweel, P.E.; Klok, F.A. & Huisman, M.V. (2019), Performance of idarucizumab as antidote of dabigatran in daily clinical practice (vol 21, pg 414, 2019), EP-Europace 21(7).
- Klok, F.A.; Barco, S. & Siegerink, B. (2019), Measuring functional limitations after venous thromboembolism: A call to action, Thrombosis Research 178: 59-62.
- Chu, G.; Versteeg, H.H.; Verschoor, A.J.; Trines, S.A.; Hemels, M.E.W.; Ay, C.; Huisman, M.V. & Klok, F.A. (2019), Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology, Blood Reviews 35: 59-67.
- Barco, S.; Klok, F.A.; Mahe, I.; Marchena, P.J.; Ballaz, A.; Rubio, C.M.; Adarraga, M.D.; Mastroiacovo, D.; Konstantinides, S.V.; Monreal, M.; Adarraga, M.D.; Aibar, M.A.; Aibar, J.; Akasbi, M.; Amado, C.; Arcelus, J.I.; Ballaz, A.; Barba, R.; Barron, M.; Barron-Andres, B.; Bascunana, J.; Blanco-Molina, A.; Camon, A.M.; Carrasco, C.; Castro, J.; Ancos, C. de; Toro, J. del; Demelo, P.; Diaz-Pedroche, M.C.; Diaz-Peromingo, J.A.; Encabo, M.; Falga, C.; Farfan, A.I.; Fernandez-Aracil, C.; Fernandez-Capitan, C.; Fernandez-Criado, M.C.; Criado, M.C.; Fidalgo, M.A.; Font, C.; Font, L.; Garcia, M.; Garcia-Bragado, F.; Garcia-Morillo, M.; Garcia-Raso, A.; Garcia-Rodenas, M.M.; Gavin, O.; Gil-Diaz, A.; Gil-Gil, F.; Guirado, L.; Gomez, V.; Gomez-Cuervo, C.; Gonzalez-Martinez, J.; Grau, E.; Gutierrez, J.; Hernandez-Blasco, L.M.; Iglesias, M.; Iglesias-Perez, C.; Jara-Palomares, L.; Jaras, M.J.; Jimenez, D.; Jou, I.; Joya, M.D.; Lima, J.; Llamas, P.; Lobo, J.L.; Lopez-Jimenez, L.; Lopez-Miguel, P.; Lopez-Nunez, J.J.; Lopez-Reyes, R.; Lopez-Saez, J.B.; Lorente, M.A.; Lorenzo, A.; Loring, M.; Lumbierres, M.; Madridano, O.; Maestre, A.; Marchena, P.J.; Martin-Asenjo, M.; Martin-Fernandez, M.; Martin-Guerra, J.M.; Mellado, M.; Monreal, M.; Morales, M.V.; Nieto, J.A.; Nunez, M.J.; Olivares, M.C.; Otalora, S.; Otero, R.; Pedrajas, J.M.; Pellejero, G.; Perez-Jacoiste, A.; Perez-Rus, G.; Peris, M.L.; Pesce, M.L.; Porras, J.A.; Rivas, A.; Rodriguez-Davila, M.A.; Rodriguez-Hernandez, A.; Rubio, C.M.; Ruiz-Artacho, P.; Ruiz-Ruiz, J.; Ruiz-Sada, P.; Sahuquillo, J.C.; Salazar, V.; Samperiz, A.; Sanchez-Munoz-Torrero, J.F.; Sancho, T.; Sanoja, I.; Soler, S.; Soto, M.J.; Surinach, J.M.; Tolosa, C.; Torres, M.I.; Trujillo-Santos, J.; Uresandi, F.; Usandizaga, E.; Valle, R.; Vidal, G.; Gutierrez, P.; Vazquez, F.J.; Vilaseca, A.; Vanassche, T.; Vandenbriele, C.; Verhamme, P.; Hirmerova, J.; Maly, R.; Salgado, E.; Benzidia, I.; Bertoletti, L.; Bura-Riviere, A.; Debourdeau, P.; Farge-Bancel, D.; Hij, A.; Mahe, I.; Moustafa, F.; Braester, A.; Brenner, B.; Ellis, M.; Tzoran, I.; Barillari, G.; Bilora, F.; Bortoluzzi, C.; Brandolin, B.; Bucherini, E.; Ciammaichella, M.; Dentali, F.; Micco, P. di; Grandone, E.; Imbalzano, E.; Lessiani, G.; Maggi, F.; Maida, R.; Mastroiacovo, D.; Mumoli, N.; Hong, N.V.; Pace, F.; Parisi, R.; Pesavento, R.; Prandoni, P.; Quintavalla, R.; Rocci, A.; Siniscalchi, C.; Tufano, A.; Visona, A.; Kigitovica, D.; Skride, A.; Sablinskis, K.; Bosevski, M.; Zdraveska, M.; Bounameaux, H.; Mazzolai, L.; Caprini, J.; Bui, H.M. & RIETE Investigators (2019), Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis, Thrombosis Research 173: 166-171.
- Wall, S.J. van der; Rein, N. van; Bemt, B. van den; Kruip, M.J.H.A.; Meijer, K.; Boome, L.C.J. te; Simmers, T.A.; Alings, A.M.; Tieleman, R.; Westerweel, P.E.; Klok, F. & Huisman, M. (2019), Performance of idarucizumab as antidote of dabigatran in daily clinical practice, EP-Europace 21(3): 414-420.
- Mol, G.C.; Dronkers, C.E.A.; Ree, M.A. van de; Pas, S.L. van der; Tegelberg-Stassen, M.J.A.M.; Sanders, F.B.M.; Koppen, S.; Weerdt, O. de; Koster, T.; Hovens, M.M.C.; Kaasjager, H.A.H.; Brouwer, R.E.; Kragten, E.; Schaar, C.G.; Spiering, W.; Arnold, W.P.; Huisman, M.V. & Klok, F.A. (2019), Elastic compression stockings one year after DVT diagnosis: Who might discontinue?, Thrombosis Research 173: 35-41.
- Huisman, M.V. & Klok, F.A. (2019), Duration of anticoagulant treatment for unprovoked deep-vein thrombosis - is prolonged long enough?, Haematologica 104(7).
- Pol, L.M. van der; Klok, F.A.; Huisman, M.V. & Artemis Study Investigators (2019), Diagnosis of Suspected Pulmonary Embolism in Pregnancy Reply.
- Barco, S.; Russo, M.; Vicaut, E.; Becattini, C.; Bertoletti, L.; Beyer-Westendorf, J.; Bouvaist, H.; Couturaud, F.; Danays, T.; Dellas, C.; Duerschmied, D.; Empen, K.; Ferrari, E.; Galie, N.; Jimenez, D.; Klok, F.A.; Kostrubiec, M.; Kozak, M.; Kupatt, C.; Lang, I.M.; Lankeit, M.; Meneveau, N.; Palazzini, M.; Pruszczyk, P.; Rugolotto, M.; Salvi, A.; Sanchez, O.; Schellong, S.; Sobkowicz, B.; Meyer, G. & Konstantinides, S.V. (2019), Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism, Clinical Research in Cardiology 108(7): 772-778.
- Hendriks, S.V.; Huisman, M.V.; Eikenboom, J.C.J.; Fogteloo, J.; Gelderblom, H.; Meer, F.J.M. van der; Stenger, W.J.E.; Verschoor, A.J.; Versteeg, H.H. & Klok, F.A. (2019), Home treatment of patients with cancer-associated venous thromboembolism, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 184: 122-128.
- Goodacre, S.; Hunt, B.J. & Nelson-Piercy, C. (2019), Diagnosis of suspected pulmonary embolism in pregnancy, New England Journal of Medicine 380(25): e49.
- Klok, F.A. & Huisman, M.V. (2019), Andexanet alfa: hét antidotum voor factor Xa-remmers?, Nederlands Tijdschrift voor Geneeskunde 163.
- Maanen, R. van; Rutten, F.H.; Klok, F.A.; Huisman, M.V.; Blom, J.W.; Moons, K.G.M. & Geersing, G.J. (2019), Validation and impact of a simplified clinical decision rule for diagnosing pulmonary embolism in primary care, BMJ Open 9(10).
- Valerio, L.; Klok, F.A. & Barco, S. (2019), Immediate and late impact of reperfusion therapies in acute pulmonary embolism, European Heart Journal Supplements 21(I): I1-I13.
- Klok, F.A.; Barco, S.; Konstantinides, S.V.; Dartevelle, P.; Fadel, E.; Jenkins, D.; Kim, N.H.; Madani, M.; Matsubara, H.; Mayer, E.; Pepke-Zaba, J.; Delcroix, M. & Lang, I.M. (2018), Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry, European Respiratory Journal 52(6).
- Huisman, M.V.; Barco, S.; Cannegieter, S.C.; Gal, G. le; Konstantinides, S.V.; Reitsma, P.H.; Rodger, M.; Noordegraaf, A.V. & Klok, F.A. (2018), Pulmonary embolism, Nature Reviews Disease Primers 4.
- Akaberi, A.; Klok, F.A.; Cohn, D.M.; Hirsch, A.; Granton, J. & Kahn, S.R. (2018), Determining the minimal clinically important difference for the PEmbQoL questionnaire, a measure of pulmonary embolism-specific quality of life, Journal of Thrombosis and Haemostasis 16(12): 2454-2461.
- Pol, L.M. van der; Dronkers, C.E.A.; Hulle, T. van der; Exter, P.L. den; Tromeur, C.; Heringhaus, C.; Mairuhu, A.T.A.; Huisman, M.V.; Hout, W.B. van den & Klok, F.A. (2018), The YEARS algorithm for suspected pulmonary embolism: shorter visit time and reduced costs at the emergency department, Journal of Thrombosis and Haemostasis 16(4): 725-733.
- Klok, F.A.; Barco, S.; Turpie, A.G.G.; Haas, S.; Kreutz, R.; Mantovani, L.G.; Gebel, M.; Herpers, M.; Bugge, J.P.; Kostantinides, S.V. & Ageno, W. (2018), Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study, British Journal of Haematology 183(3): 457-465.
- Mens, T.E. van; Pol, L.M. van der; Es, N. van; Bistervels, I.M.; Mairuhu, A.T.A.; Hulle, T. van der; Klok, F.A.; Huisman, M.V. & Middeldorp, S. (2018), Sex-specific performance of pre-imaging diagnostic algorithms for pulmonary embolism, Journal of Thrombosis and Haemostasis 16(5): 858-865.
- Fronas, S.; Wik, H.S.; Dahm, A.E.A.; Jorgensen, C.T.; Gleditsch, J.; Raouf, N.; Klok, E.A. & Ghanima, W. (2018), Safety of D-Dimer As a Stand-Alone Test for the Exclusion of Deep Vein Thrombosis Compared to Other Strategies, Blood 132.
- Pol, L.M. van der; Tromeur, C.; Bistervels, I.; Bemmel, T. van; Couturaud, F.; Faber, L.M.; Mairuhu, A.T.A.; Middeldorp, S.; Wolde, M. ten; Klok, E.A. & Huisman, M.V. (2018), Safety and Efficiency of the YEARS Diagnostic Algorithm for Pregnant Patients with Clinically Suspected Acute Pulmonary Embolism-the Artemis Study, Blood 132.
- Sista, A.K. & Klok, F.A. (2018), Late outcomes of pulmonary embolism: The post-PE syndrome, Thrombosis Research 164: 157-162.
- Barco, S.; Konstantinides, S.; Huisman, M.V. & Klok, F.A. (2018), Diagnosis of recurrent venous thromboembolism, Thrombosis Research 163: 229-235.
- Scheres, L.J.J.; Brekelmans, M.P.A.; Ageno, W.; Ay, C.; Buller, H.R.; Eichinger, S.; Hutten, B.A.; Klok, F.A.; Middeldorp, S.; Schreiber, K.; Stach, K.; Blondon, M. & Delluc, A. (2018), Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study, BJOG: An International Journal of Obstetrics and Gynaecology 125(12): 1581-1589.
- Kraaijpoel, N.; Toorop, M.M.A.; Bossuyt, P.M.; Klok, F.A.; Buller, H.R. & Es, N. van (2018), Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: comment, Journal of Thrombosis and Haemostasis 16(7): 1445-1448.
- Fronas, S.G.; Wik, H.S.; Dahm, A.E.A.; Jorgensen, C.T.; Gleditsch, J.; Raouf, N.; Klok, F.A. & Ghanima, W. (2018), Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies, Journal of Thrombosis and Haemostasis 16(12): 2471-2481.
- Dronkers, C.E.A.; Mol, G.C.; Maraziti, G.; Ree, M.A. van de; Huisman, M.V.; Becattini, C. & Klok, F.A. (2018), Predicting Post-Thrombotic Syndrome with Ultrasonographic Follow-Up after Deep Vein Thrombosis: A Systematic Review and Meta-Analysis, Thrombosis and Haemostasis 118(8): 1428-1438.
- Huisman, M.V. & Klok, F.A. (2018), Pharmacological properties of betrixaban, European Heart Journal Supplements 20(E): E12-E15.
- Dronkers, C.E.A.; Lijfering, W.M.; Teichert, M.; Meer, F.J.M. van der; Klok, F.A.; Cannegieter, S.C. & Huisman, M.V. (2018), Persistence to direct oral anticoagulants for acute venous thromboembolism, Thrombosis Research 167: 135-141.
- Dronkers, C.E.A.; Klok, F.A.; Haren, G.R. van; Gleditsch, J.; Westerlund, E.; Huisman, M.V. & Kroft, L.J.M. (2018), Diagnosing upper extremity deep vein thrombosis with non-contrast-enhanced Magnetic Resonance Direct Thrombus Imaging: A pilot study, Thrombosis Research 163: 47-50.
- Tromeur, C.; Pol, L.M. van der; Mairuhu, A.T.A.; Leroyer, C.; Couturaud, F.; Huisman, M.V. & Klok, F.A. (2018), Novel Anticoagulant Treatment for Pulmonary Embolism with Direct Oral Anticoagulants Phase 3 Trials and Clinical Practice, Seminars in Interventional Radiology 35(2): 83-91.
- Pol, L.M. van der; Hulle, T. van der; Mairuhu, A.T.A.; Huisman, M.V. & Klok, F.A. (2018), Combination of Pulmonary Embolism Rule-out Criteria and YEARS Algorithm in a European Cohort of Patients with Suspected Pulmonary Embolism, Thrombosis and Haemostasis 118(3): 547-552.
- Barco, S.; Ende-Verhaar, Y.M.; Becattini, C.; Jimenez, D.; Lankeit, M.; Huisman, M.V.; Konstantinides, S.V. & Klok, F.A. (2018), Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis, European Heart Journal 39(47): 4186-4195.
- Boon, G.J.A.M.; Dam, L.F. van; Klok, F.A. & Huisman, M.V. (2018), Management and treatment of deep vein thrombosis in special populations, Expert Review of Hematology 11(9): 685-695.
- Pol, L.M. van der; Bistervels, I.M.; Mens, T.E. van; Hulle, T. van der; Beenen, L.F.M.; Exter, P.L. den; Kroft, L.J.M.; Mairuhu, A.T.A.; Middeldorp, S.; Werkhoven, J.M. van; Wolde, M. ten; Huisman, M.V. & Klok, F.A. (2018), Lower prevalence of subsegmental pulmonary embolism after application of the YEARS diagnostic algorithm, British Journal of Haematology 183(4): 629-635.
- Huisman, M.V.; Ferreira, M.; Feuring, M.; Fraessdorf, M. & Klok, F.A. (2018), Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism, Journal of Thrombosis and Haemostasis 16(9): 1775-1778.
- Tavoly, M.; Wik, H.S.; Sirnes, P.A.; Jelsness-Jorgensen, L.P.; Ghanima, J.P.; Klok, F.A.; Sandset, P.M. & Ghanima, W. (2018), The impact of post-pulmonary embolism syndrome and its possible determinants, Thrombosis Research 171: 84-91.
- Boon, G.J.A.M.; Dam, L.F. van; Klok, F.A. & Huisman, M.V. (2018), Management and Treatment of Deep Vein Thrombosis in Special Populations, Expert Review of Hematology 11.
- Wall, S. van der; Hendriks, S.; Huisman, M. & Klok, F.A. (2018), Home treatment of acute pulmonary embolism: state of the art in 2018, Current Opinion in Pulmonary Medicine 24(5): 425-431.
- Ende-Verhaar, Y.M.; Hout, W.B. van den; Bogaard, H.J.; Meijboom, L.J.; Huisman, M.V.; Symersky, P.; Vonk-Noordegraaf, A. & Klok, F.A. (2018), Healthcare utilization in chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Journal of Thrombosis and Haemostasis 16(11): 2168-2174.
- Wall, S.J. van der; Olsthoorn, J.R.; Heuts, S.; Klautz, R.J.M.; Tomsic, A.; Jansen, E.K.; Vonk, A.B.A.; Nia, P.S.; Klok, F.A. & Huisman, M.V. (2018), Antithrombotic therapy after mitral valve repair: VKA or aspirin?, Journal of Thrombosis and Thrombolysis 46(4): 473-481.
- Wall, S.J. van der; Olsthoorn, J.R.; Heuts, S.; Klautz, R.J.M.; Tomsic, A.; Jansen, E.K.; Vonk, A.B.A.; Nia, P.S.; Klok, F.A. & Huisman, M.V. (2018), Antithrombotic therapy after mitral valve repair: VKA or aspirin? (vol 46, pg 473, 2018), Journal of Thrombosis and Thrombolysis 46(4): 482-482.
- Klok, F.A.; Delcroix, M. & Bogaard, H.J. (2018), Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism, Journal of Thrombosis and Haemostasis 16(6): 1040-1051.
- Zielinski, G.D.; Teichert, M.; Klok, F.A.; Rosendaal, F.R.; Huisman, M.V.; Cannegieter, S.C. & Lijfering, W.M. (2018), Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints, Pharmacoepidemiology and Drug Safety 27(12): 1371-1378.
- Jimenez, D.; Martin-Saborido, C.; Muriel, A.; Zamora, J.; Morillo, R.; Barrios, D.; Klok, F.A.; Huisman, M.V.; Tapson, V. & Yusen, R.D. (2018), Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis, Thorax 73(5): 464-471.
- Dronkers, C.E.A.; Klok, F.A.; Haren, G.R. van; Gleditsch, J.; Westerlund, E.; Huisman, M.V. & Kroft, L.J.M. (2018), Diagnosing upper extremity deep vein thrombosis with non-contrast-enhanced Magnetic Resonance Direct Thrombus Imaging: A pilot study, Thrombosis Research 163: 47-50.
- Schol-Gelok, S.; Hulle, T. van der; Biedermann, J.S.; Gelder, T. van; Klok, F.A.; Pol, L.M. van der; Versmissen, J.; Huisman, M.V. & Kruip, M.J.H.A. (2018), Clinical effects of antiplatelet drugs and statins on D-dimer levels, European Journal of Clinical Investigation 48(7).
- Barco, S.; Vicaut, E.; Klok, F.A.; Lankeit, M.; Meyer, G.; Konstantinides, S.V. & PEITHO Investigators (2018), Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials.
- Klok, F.A.; Meijboom, L.J.; Kroft, L.J.M.; Beenen, L.F.M.; Boon, G.J.A.M.; Middeldorp, S.; Huisman, M.V.; Bogaard, H.J.; Noordegraaf, A.V. & Ende-Verhaar, Y.M. (2018), Identification of chronic thromboembolic pulmonary hypertension on standard computed tomography pulmonary angiography for suspected acute pulmonary embolism, European Heart Journal 39: 319-319.
- Wall, S.J. van der; Pol, L.M. van der; Ende-Verhaar, Y.M.; Cannegieter, S.C.; Schulman, S.; Prandoni, P.; Rodger, M.; Huisman, M.V. & Klok, F.A. (2018), Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review, European Respiratory Review 27(150).
- Klok, F.A. & Hoeper, M.M. (2017), Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat, European Respiratory Journal 49(5).
- Barco, S.; Klok, F.A. & Dentali, F. (2017), Letter by Barco et al Regarding Article, "Restarting Anticoagulant Therapy After Intracranial Hemorrhage: A Systematic Review and Meta-Analysis", Stroke 48(9): E266-E266.
- Tromeur, C.; Pol, L.M. van der; Klok, F.A.; Couturaud, F. & Huisman, M.V. (2017), Pitfalls in the diagnostic management of pulmonary embolism in pregnancy, Thrombosis Research 151: S86-S91.
- Carrier, M. & Klok, F.A. (2017), Symptomatic subsegmental pulmonary embolism: to treat or not to treat?, Hematology: 237-241.
- Es, N. van; Kraaijpoel, N.; Klok, F.A.; Huisman, M.V.; Exter, P.L. den; Mos, I.C.M.; Galipienzo, J.; Buller, H.R. & Bossuyt, P.M. (2017), The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis, Journal of Thrombosis and Haemostasis 15(4): 678-684.
- Hulle, T. van der; Cheung, W.Y.; Kooij, S.; Beenen, L.F.M.; Bemmel, T. van; Es, J. van; Faber, L.M.; Hazelaar, G.M.; Heringhaus, C.; Hofstee, H.; Hovens, M.M.C.; Kaasjager, K.A.H.; Klink, R.C.J. van; Kruip, M.J.H.A.; Loeffen, R.F.; Mairuhu, A.T.A.; Middeldorp, S.; Nijkeuter, M.; Pol, L.M. van der; Schol-Gelok, S.; Wolde, M. ten; Klok, F.A.; Huisman, M.V. & YEARS Study Grp (2017), Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study, Lancet 390(10091): 289-297.
- Pol, L.M. van der; Hulle, T. van der; Cheung, Y.W.; Mairuhu, A.T.A.; Schaar, C.G.; Faber, L.M.; Wolde, M. ten; Hofstee, H.M.A.; Hovens, M.M.C.; Nijkeuter, M.; Klink, R.C.J. van; Kruip, M.J.H.A.; Middeldorp, S.; Huisman, M.V. & Klok, F.A. (2017), No added value of the age-adjusted D-dimer cut-off to the YEARS algorithm in patients with suspected pulmonary embolism, Journal of Thrombosis and Haemostasis 15(12): 2317-2324.
- Ende-Verhaar, Y.M.; Huisman, M.V. & Klok, F.A. (2017), To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Thrombosis Research 151: 1-7.
- Kohn, M.A.; Klok, F.A. & Es, N. van (2017), D-dimer Interval Likelihood Ratios for Pulmonary Embolism, Academic Emergency Medicine 24(7): 832-837.
- Klok, F.A.; Schreiber, K.; Stach, K.; Ageno, W.; Middeldorp, S.; Eichinger, S.; Delluc, A.; Blondon, M. & Ay, C. (2017), Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice Combined results of a systematic review, expert panel opinion and an international survey, Thrombosis Research 153: 101-107.
- Ende-Verhaar, Y.M.; Cannegieter, S.C.; Noordegraaf, A.V.; Delcroix, M.; Pruszczyk, P.; Mairuhu, A.T.A.; Huisman, M.V. & Klok, F.A. (2017), Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature, European Respiratory Journal 49(2).
- Es, N. van; Hulle, T. van der; Buller, H.R.; Klok, F.A.; Huisman, M.V.; Galipienzo, J. & Nisio, M. di (2017), Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism?, Journal of Thrombosis and Haemostasis 15(2): 323-328.
- Klok, F.A.; Barco, S. & Konstantinides, S.V. (2017), External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism, Thrombosis and Haemostasis 117(6): 1164-1170.
- Wall, S.J. van der; Klok, F.A.; Exter, P.L. den; Barrios, D.; Morillo, R.; Cannegieter, S.C.; Jimenez, D. & Huisman, M.V. (2017), Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice, Journal of Thrombosis and Haemostasis 15(1): 74-79.
- Pol, L.M. van der; Mairuhu, A.T.A.; Tromeur, C.; Couturaud, F.; Huisman, M.V. & Klok, F.A. (2017), Use of clinical prediction rules and D-dimer tests in the diagnostic management of pregnant patients with suspected acute pulmonary embolism, Blood Reviews 31(2): 31-36.
- Ende-Verhaar, Y.M.; Kroft, L.J.M.; Mos, I.C.M.; Huisman, M.V. & Klok, F.A. (2017), Accuracy and reproducibility of CT right-to-left ventricular diameter measurement in patients with acute pulmonary embolism, PLoS ONE 12(11).
- Klok, F.A.; Ageno, W.; Barco, S.; Binder, H.; Brenner, B.; Duerschmied, D.; Empen, K.; Faggiano, P.; Ficker, J.H.; Galie, N.; Ghuysen, A.; Held, M.; Heydenreich, N.; Huisman, M.V.; Jimenez, D.; Kozak, M.; Lang, I.M.; Lankeit, M.; Munzel, T.; Petris, A.; Pruszczyk, P.; Quitzau, K.; Schellong, S.; Schmidt, K.H.; Stefanovic, B.S.; Verschuren, F.; Wolf-Puetz, A.; Meyer, G.; Konstantinides, S.V. & PEITHO-2 Investigators (2017), Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study, Thrombosis and Haemostasis 117(12): 2425-2434.
- Dronkers, C.E.A.; Ende-Verhaar, Y.M.; Kyrle, P.A.; Righini, M.; Cannegieter, S.C.; Huisman, M.V.; Klok, F.A. & Subcomm Predictive Diag Variables (2017), Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH, Journal of Thrombosis and Haemostasis 15(11): 2270-2273.
- Klok, F.A. & Huisman, M.V. (2017), Management of incidental pulmonary embolism, European Respiratory Journal 49(6).
- Exter, P.L. den; Hooijer, J.; Hulle, T. van der; Oosten, J.P. van; Dekkers, O.M.; Klok, F.A. & Huisman, M.V. (2017), Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice, Thrombosis and Haemostasis 117(11): 2163-2167.
- Dronkers, C.E.A.; Hulle, T. van der; Gal, G. le; Kyrle, P.A.; Huisman, M.V.; Cannegieter, S.C.; Klok, F.A. & Subcomm Predictive Diagnost (2017), Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH, Journal of Thrombosis and Haemostasis 15(5): 1040-1043.
- Huller, T. van der; Es, N. van; Exter, P.L. den; Es, J. van; Mos, I.C.M.; Douma, R.A.; Kruip, M.J.H.A.; Hovens, M.M.C.; Woldes, M. ten; Nijkeuter, M.; Cate, H. ten; Kamphuisen, P.W.; BuIler, H.R.; Huisman, M.V. & Klok, F.A. (2017), Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability?, Thrombosis and Haemostasis 117(8): 1622-1629.
- Tromeur, C.; Pol, L.M. van der; Couturaud, F.; Klok, F.A. & Huisman, M.V. (2017), Therapeutic management of acute pulmonary embolism, Expert Review of Respiratory Medicine 11(8): 641-648.
- Exter, P.L. den; Hooijer, J.; Hulle, T. van der; Oosten, J.P. van; Dekkers, O.M.; Klok, F.A. & Huisman, M.V. (2017), Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice, Thrombosis and Haemostasis 117(11): 2163—2167.
- Klok, F.A.; Schreiber, K.; Stach, K.; Ageno, W.; Middeldorp, S.; Eichinger, S.; Delluc, A.; Blondon, M. & Ay, C. (2017), Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 153: 101—107.
- Klok, F.A.; Dronkers, C.E.A.; Pol, L.M. van der; Hulle, T. van der; Tromeur, C.; Heringhaus, C.; Mairuhu, A.T.A. & Huisman, M.V. (2017), The YEARS algorithm for suspected pulmonary embolism leads to much shorter diagnostic turnaround time than conventional algorithms, European Heart Journal 38: 1036-1037.
- Exter, P.L. den; Klok, F.A. & Huisman, M.V. (2017), Reply: N-Terminal Pro-Brain Natriuretic Peptide Trial Design, American Journal of Respiratory and Critical Care Medicine 196(4): 531-532.
- Squizzato, A.; Pomero, F.; Allione, A.; Priotto, R.; Riva, N.; Huisman, M.V.; Klok, F.A.; Stein, P.D.; Guasti, L.; Fenoglio, L.; Dentali, F. & Ageno, W. (2017), Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis, Thrombosis Research 154: 64-72.
- Bijl, N. van der; Klok, F.A.; Huisman, M.V.; Roos, A. de & Kroft, L.J.M. (2016), Coronary or thoracic artery calcium score in provoked and unprovoked pulmonary embolism: a case-control study, Journal of Thrombosis and Haemostasis 14(5): 931-935.
- Es, N. van; Hulle, T. van der; Es, J. van; Exter, P.L. den; Douma, R.A.; Goekoop, R.J.; Mos, I.C.M.; Galipienzo, J.; Kamphuisen, P.W.; Huisman, M.V.; Klok, F.A.; Buller, H.R. & Bossuyt, P.M. (2016), Wells Rule and D-Dimer Testing to Rule Out Pulmonary Embolism A Systematic Review and Individual-Patient Data Meta-analysis, Annals of Internal Medicine 165(4): 253-+.
- Mol, G.C.; Ree, M.A. van de; Klok, F.A.; Tegelberg, M.J.A.M.; Sanders, F.B.M.; Koppen, S.; Weerdt, O. de; Koster, T.; Hovens, M.M.C.; Kaasjager, H.A.H.; Brouwer, R.E.; Kragten, E.; Schaar, C.G.; Spiering, W.; Arnold, W.P.; Biesma, D.H. & Huisman, M.V. (2016), One versus two years of elastic compression stockings for prevention of post-thrombotic syndrome (OCTAVIA study): randomised controlled trial, BMJ 353.
- Exter, P.L. den; Zondag, W.; Klok, F.A.; Brouwer, R.E.; Dolsma, J.; Eijsvogel, M.; Faber, L.M.; Gerwen, M. van; Grootenboers, M.J.; Heller-Baan, R.; Hovens, M.M.; Jonkers, G.J.P.M.; Kralingen, K.W. van; Melissant, C.F.; Peltenburg, H.; Post, J.P.; Ree, M.A. van de; Vlasveld, L.T.; Vreede, M.J. de; Huisman, M.V. & Vesta Study Investigators (2016), Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism A Randomized Clinical Trial, American Journal of Respiratory and Critical Care Medicine 194(8): 998-1006.
- Dronkers, C.E.A.; Klok, F.A. & Huisman, M.V. (2016), Current and future perspectives in imaging of venous thromboembolism, Journal of Thrombosis and Haemostasis 14(9): 1696-1710.
- Rein, N. van; Cannegieter, S.C.; Cessie, S. le; Rosendaal, F.R.; Reitsma, P.H.; Meer, F.J.M. van der & Lijfering, W.M. (2016), Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects, American Journal of Epidemiology 183(10): 930-936.
- Heestermans, M.; Salloum-Asfar, S.; Salvatori, D.; Laghmani, E.; Luken, B.M.; Zeerleder, S.S.; Spronk, H.M.H.; Korporaal, S.J.; Wagenaar, G.T.M.; Reitsma, P.H. & Vlijmen, B.J.M. van (2016), Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice, Blood 127(21): 2630-2637.
- Biedermann, J.S.; Cannegieter, S.C.; Roest, M.; Meer, F.J.M. van der; Reitsma, P.H.; Kruip, M.J.H.A. & Lijfering, W.M. (2016), Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial, Journal of Thrombosis and Haemostasis 14(7): 1404-1409.
- Klok, F.A.; Niemann, C.; Dellas, C.; Hasenfuss, G.; Konstantinides, S. & Lankeit, M. (2016), Performance of five different bleeding-prediction scores in patients with acute pulmonary embolism, Journal of Thrombosis and Thrombolysis 41(2): 312-320.
- Rein, N. van; Lijfering, W.M.; Bos, M.H.A.; Herruer, M.H.; Vermaas, H.W.; Meer, F.J.M. van der & Reitsma, P.H. (2016), Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists, PLoS ONE 11(12).
- Tregouet, D.A.; Delluc, A.; Roche, A.; Derbois, C.; Olaso, R.; Germain, M.; Andrade, M. de; Tang, W.; Chasman, D.I.; Vlieg, A.V.; Reitsma, P.H.; Kabrhel, C.; Smith, N. & Morange, P.E. (2016), Is there still room for additional common susceptibility alleles for venous thromboembolism?, Journal of Thrombosis and Haemostasis 14(9): 1798-1802.
- Rein, N. van; Cessie, S. le; Vliet, I.P. van; Reitsma, P.H.; Meer, F.J.M. van der; Lijfering, W.M. & Cannegieter, S.C. (2016), Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors, Journal of Thrombosis and Haemostasis 14(5): 948-952.
- Heestermans, M.; Cunha, M.L.R.; Reitsma, P.H.; Zeerleder, S.S.; Middeldorp, S. & Vlijmen, B.J.M. van (2016), Circulating nucleosomes and elastase alpha 1-antitrypsin complexes and the novel thrombosis susceptibility locus SLC44A2, Thrombosis Research 142: 8-10.
- Simeoni, I.; Stephens, J.C.; Hu, F.Y.; Deevi, S.V.V.; Megy, K.; Bariana, T.K.; Lentaigne, C.; Schulman, S.; Sivapalaratnam, S.; Vries, M.J.A.; Westbury, S.K.; Greene, D.; Papadia, S.; Alessi, M.C.; Attwood, A.P.; Ballmaier, M.; Baynam, G.; Bermejo, E.; Bertoli, M.; Bray, P.F.; Bury, L.; Cattaneo, M.; Collins, P.; Daugherty, L.C.; Favier, R.; French, D.L.; Furie, B.; Gattens, M.; Germeshausen, M.; Ghevaert, C.; Goodeve, A.C.; Guerrero, J.A.; Hampshire, D.J.; Hart, D.P.; Heemskerk, J.W.M.; Henskens, Y.M.C.; Hill, M.; Hogg, N.; Jolley, J.D.; Kahr, W.H.; Kelly, A.M.; Kerr, R.; Kostadima, M.; Kunishima, S.; Lambert, M.P.; Liesner, R.; Lopez, J.A.; Mapeta, R.P.; Mathias, M.; Millar, C.M.; Nathwani, A.; Neerman-Arbez, M.; Nurden, A.T.; Nurden, P.; Othman, M.; Peerlinck, K.; Perry, D.J.; Poudel, P.; Reitsma, P.; Rondina, M.T.; Smethurst, P.A.; Stevenson, W.; Szkotak, A.; Tuna, S.; Geet, C. van; Whitehorn, D.; Wilcox, D.A.; Zhang, B.; Revel-Vilk, S.; Gresele, P.; Bellissimo, D.B.; Penkett, C.J.; Laffan, M.A.; Mumford, A.D.; Rendon, A.; Gomez, K.; Freson, K.; Ouwehand, W.H. & Turro, E. (2016), A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders, Blood 127(23): 2791-2803.
- Pasha, S.M.; Tan, M.; Vellinga, T.F.D.V.; Klok, F.A. & Huisman, M.V. (2016), Risk of atherothrombotic events in patients after proximal deep-vein thrombosis, Blood Coagulation and Fibrinolysis 27(1): 13-18.
- Tavoly, M.; Utne, K.K.; Jelsness-Jorgensen, L.P.; Wik, H.S.; Klok, F.A.; Sandset, P.M. & Ghanima, W. (2016), Health-related quality of life after pulmonary embolism: a cross-sectional study, BMJ Open 6(11).
- Dronkers, C.E.A.; Tan, M.; Mol, G.C.; Sol, A.I. del; Ree, M.A. van de; Huisman, M.V. & Klok, F.A. (2016), Evaluation of the new simple and objective clinical decision rule "I-DVT" in patients with clinically suspected acute deep vein thrombosis, Thrombosis Research 141: 112-118.
- Hulle, T. van der; Exter, P.L. den; Planquette, B.; Meyer, G.; Soler, S.; Monreal, M.; Jimenez, D.; Portillo, A.K.; O'Connell, C.; Liebman, H.A.; Shteinberg, M.; Adir, Y.; Tiseo, M.; Bersanelli, M.; Abdel-Razeq, H.N.; Mansour, A.H.; Donnelly, O.G.; Radhakrishna, G.; Ramasamy, S.; Bozas, G.; Maraveyas, A.; Shinagare, A.B.; Hatabu, H.; Nishino, M.; Huisman, M.V. & Klok, F.A. (2016), Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients, Journal of Thrombosis and Haemostasis 14(1): 105-113.
- Hulle, T. van der; Dronkers, C.E.A.; Huisman, M.V. & Klok, F.A. (2016), Current standings in diagnostic management of acute venous thromboembolism: Still rough around the edges, Blood Reviews 30(1): 21-26.
- Keeling, D.; Klok, F.A. & Gal, G. le (2016), Controversies in venous thromboembolism-2015, Blood Reviews 30(1): 27-33.
- Hulle, T. van der; Exter, P.L. den; Hoven, P. van den; Hoeven, J.J. van der; Meer, F.J.M. van der; Eikenboom, J.; Huisman, M.V. & Klok, F.A. (2016), Cohort Study on the Management of Cancer-Associated Venous Thromboembolism Aimed at the Safety of Stopping Anticoagulant Therapy in Patients Cured of Cancer, Chest 149(5): 1245-1251.
- Klok, F.A.; Dzikowska-Diduch, O.; Kostrubiec, M.; Vliegen, H.W.; Pruszczyk, P.; Hasenfuss, G.; Huisman, M.V.; Konstantinides, S. & Lankeit, M. (2016), Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Journal of Thrombosis and Haemostasis 14(1): 121-128.
- Hulle, T. van der; Dronkers, C.E.A.; Klok, F.A. & Huisman, M.V. (2016), Recent developments in the diagnosis and treatment of pulmonary embolism, Journal of Internal Medicine 279(1): 16-29.
- Es, N. van; Hulle, T. van der; Es, J. van; Exter, P.L. den; Douma, R.A.; Goekoop, R.J.; Mos, I.C.M.; Galipienzo, J.; Kamphuisen, P.W.; Huisman, M.V.; Klok, F.A.; Buller, H.R. & Bossuyt, P.M. (2016), Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysis, Annals of Internal Medicine 165(4): 253—261.
- Exter, P.L. den; Zondag, W.; Klok, F.A.; Brouwer, R.E.; Dolsma, J.; Eijsvogel, M.; Faber, L.M.; Gerwen, M. van; Grootenboers, M.J.; Heller-Baan, R.; Hovens, M.M.; Jonkers, G.J.P.M.; Kralingen, K.W. van; Melissant, C.F.; Peltenburg, H.; Post, J.P.; Ree, M.A. van de; Vlasveld, L.T.; Vreede, M.J. de; Huisman, M.V. & Vesta Study Investigators (2016), Efficacy and safety of outpatient treatment based on the hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism: A randomized clinical trial, American Journal of Respiratory and Critical Care Medicine 194(8): 998-1006.
- Ende-Verhaar, Y.M.; Cannegieter, S.C.; Noordegraaf, A.V.; Delcroix, M.; Pruszczyk, P.; Mairuhu, A.T.A.; Huisman, M.V. & Klok, F.A. (2016), Varying incidences of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the final thread that links them all, European Heart Journal 37: 406-407.
- Klok, F.A.; Hosel, V.; Clemens, A.; Yollo, W.D.; Tilke, C.; Schulman, S.; Lankeit, M. & Konstantinides, S.V. (2016), Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment, European Respiratory Journal 48(5): 1369-1376.
- Dronkers, C.E.A.; Hulle, T. van der; Ende-Verhaar, Y.M.; Cannegieter, S.C.; Huisman, M.V. & Klok, F.A. (2016), Association of disease prevalence and failure rate in diagnostic management studies in suspected pulmonary embolism: towards a new tailored standard for future studies, European Heart Journal 37: 953-953.
- Klok, F.A.; Sleddering, M.A. & Huisman, M.V. (2015), Imaging Tests for Suspected Deep Vein Thrombosis, JAMA Internal Medicine 175(11): 1873-1874.
- Huisman, M.V. & Klok, F.A. (2015), Current challenges in diagnostic imaging of venous thromboembolism, Blood 126(21): 2376-2382.
- Klok, F.A.; Kooiman, J.; Huisman, M.V.; Konstantinides, S. & Lankeit, M. (2015), Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review, European Respiratory Journal 45(1): 201-210.
- Hulle, T. van der; Tan, M.; Exter, P.L. den; Roosmalen, M.J.G. van; Meer, F.J.M. van der; Eikenboom, J.; Huisman, M.V. & Klok, F.A. (2015), Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism, Haematologica 100(2): 188-193.
- Kooiman, J.; Exter, P.L. den; Kilicsoy, I.; Cannegieter, S.C.; Eikenboom, J.; Huisman, M.V.; Klok, F.A. & Versteeg, H.H. (2015), Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism, Journal of Thrombosis and Thrombolysis 40(3): 323-330.
- Groeneveld, D.J.; Bekkum, T.; Dirven, R.J.; Wang, J.W.; Voorberg, J.; Reitsma, P.H. & Eikenboom, J. (2015), Angiogenic characteristics of blood outgrowth endothelial cells from patients with von Willebrand disease, Journal of Thrombosis and Haemostasis 13(10): 1854-1866.
- Valls, M.J.F.; Hulle, T. van der; Exter, P.L. den; Mos, I.C.M.; Huisman, M.V. & Klok, F.A. (2015), Performance of a diagnostic algorithm based on a prediction rule, D-dimer and CT-scan for pulmonary embolism in patients with previous venous thromboembolism A systematic review and meta-analysis, Thrombosis and Haemostasis 113(2): 406-413.
- Klok, F.A.; Tan, M. & Huisman, M.V. (2015), F-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Enables the Detection of Recurrent Same-Site Deep Vein Thrombosis by Illuminating Recently Formed, Neutrophil-Rich Thrombus, Circulation 131(24): E530-E530.
- Klok, F.A.; Tesche, C.; Rappold, L.; Dellas, C.; Hasenfuss, G.; Huisman, M.V.; Konstantinides, S. & Lankeit, M. (2015), External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Thrombosis Research 135(5): 796-801.
- Kooiman, J.; Hagen, N. van; Sol, A.I. del; Planken, E.V.; Lip, G.Y.H.; Meer, F.J.M. van der; Cannegieter, S.C.; Klok, F.A. & Huisman, M.V. (2015), The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment, PLoS ONE 10(4).
- Hulle, T.V.D.; Exter, P.L. den; Hoven, P. van den; Hoeven, J.J. van der; Meer, F.J. van der; Eikenboom, J.; Huisman, M.V. & Klok, F.A. (2015), Safety of stopping anticoagulant treatment for cancer-associated venous thromboembolism after reaching complete remission from cancer, Journal of Thrombosis and Haemostasis 13: 987-987.
- Exter, P.L. den; Hulle, T. van der; Hartmann, I.J.C.; Jimenez, D.; Klok, F.A.; Huisman, M.V. & Kroft, L.J.M. (2015), Reliability of diagnosing incidental pulmonary embolism in cancer patients, Thrombosis Research 136(3): 531-534.
- Klok, F.A.; Dzikowska-Diduch, O.; Kostrubiec, M.; Vliegen, H.W.; Pruszczyk, P.; Hasenfuss, G.; Huisman, M.V.; Konstantinides, S. & Lankeit, M. (2015), Derivation of a new score to predict chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, Journal of Thrombosis and Haemostasis 13: 976-976.
- Klok, F.A.; Dzikowska-Diduc, O.; Kostrubiec, M.; Vliegen, H.W.; Pruszczyk, P.; Hasenfuss, G.; Huisman, M.V.; Konstantinides, S. & Lankeit, M. (2015), Derivation of a new score to predict chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, European Heart Journal 36: 707-707.
- Klok, F.A. & Huisman, M.V. (2014), Thrombolysis for hemodynamically stable pulmonary embolism: Time to close the book?, Thrombosis Research 134(6): 1169-1170.
- Exter, P.L. den; Hulle, T. van der; Klok, F.A. & Huisman, M.V. (2014), The Newer Anticoagulants in Thrombosis Control in Cancer Patients, Seminars in Oncology 41(3): 339-345.
- Pasha, S.M.; Klok, F.A.; Bijl, N. van der; Roos, A. de; Kroft, L.J.M. & Huisman, M.V. (2014), Right ventricular function and thrombus load in patients with pulmonary embolism and diagnostic delay, Journal of Thrombosis and Haemostasis 12(2): 172-176.
- Rochat, M.; Mean, M.; Limacher, A.; Hugli, O.; Klok, F.A.; Cohn, D.M. & Aujesky, D. (2014), Quality of life after pulmonary embolism: validation of the French version of the PEmb-QoL questionnaire, Health and Quality of Life Outcomes 12.
- Hulle, T. van der; Huisman, M.V. & Klok, F.A. (2014), Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: reply, Journal of Thrombosis and Haemostasis 12(12): 2138-2139.
- Tan, M.; Mol, G.C.; Rooden, C.J. van; Klok, F.A.; Westerbeek, R.E.; Sol, A.I. del; Ree, M.A. van de; Roos, A. de & Huisman, M.V. (2014), Magnetic resonance direct thrombus imaging differentiates acute recurrent ipsilateral deep vein thrombosis from residual thrombosis, Blood 124(4): 623-627.
- Klok, F.A.; Tesche, C.; Rappold, L.; Dellas, C.; Hasenfuss, G.; Huisman, M.V.; Konstantinides, S. & Lankeit, M. (2014), External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism, European Heart Journal 35: 915-915.
- Kooiman, J.; Rein, N. van; Spaans, B.; Beers, K.A.J. van; Bank, J.R.; Peppel, W.R.V. de; Sol, A.I. del; Cannegieter, S.C.; Rabelink, T.J.; Lip, G.Y.H.; Klok, F.A. & Huisman, M.V. (2014), Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease, PLoS ONE 9(5).
- Krol, C.G.; Klok, F.A. & Koning, E.J.P. de (2014), Diplopia as the Presenting Symptom of Type 1 Diabetes, Diabetes Care 37(3): E45-E46.
- Hulle, T. van der; Exter, P.L. den; Kooiman, J.; Hoeven, J.J.M. van der; Huisman, M.V. & Klok, F.A. (2014), Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism, Journal of Thrombosis and Haemostasis 12(7): 1116-1120.
- Hulle, T. van der; Kooiman, J.; Exter, P.L. den; Dekkers, O.M.; Klok, F.A. & Huisman, M.V. (2014), Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta- analysis, Journal of Thrombosis and Haemostasis 12(3): 320-328.
- Hulle, T. van der; Exter, P.L. den; Mos, I.C.M.; Kamphuisen, P.W.; Hovens, M.M.C.; Kruip, M.J.H.A.; Es, J. van; Cate, H. ten; Huisman, M.V. & Klok, F.A. (2014), Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients, British Journal of Haematology 167(5): 681-686.
- Exter, P.L. den; Hulle, T. van der; Klok, F.A. & Huisman, M.V. (2014), Advances in the diagnosis and management of acute pulmonary embolism, Thrombosis Research 133: S10-S16.
- Exter, P.L. den; Hoven, P. van den; Hulle, T. van der; Mos, I.C.M.; Douma, R.A.; Es, J. van; Huisman, M.V. & Klok, F.A. (2014), Performance of the revised Geneva score in patients with a delayed suspicion of pulmonary embolism, European Respiratory Journal 43(6): 1801-1804.
- Klok, F.A.; Hulle, T. van der; Exter, P.L. den; Lankeit, M.; Huisman, M.V. & Konstantinides, S. (2014), The post-PE syndrome: a new concept for chronic complications of pulmonary embolism, Blood Reviews 28(6): 221-226.
- Mos, I.C.M.; Douma, R.A.; Erkens, P.M.G.; Kruip, M.J.H.A.; Hovens, M.M.; Houten, A.A. van; Hofstee, H.M.A.; Kooiman, J.; Klok, F.A.; Buller, H.R.; Kamphuisen, P.W.; Huisman, M.V. & Prometheus Study Grp (2014), Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm, Thrombosis Research 133(6): 1039-1044.
- Rochat, M.; Mean, M.; Limacher, A.; Hugli, O.; Klok, F.A.; Cohn, D.M. & Aujesky, D. (2014), Quality of life after pulmonary embolism: validation of the French version of the PEmb-QoL questionnaire, Health and Quality of Life Outcomes 12: 174.
- Hulle, T. van der; Kooiman, J.; Exter, P.L. den; Dekkers, O.M.; Klok, F.A. & Huisman, M.V. (2014), Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis, Journal of Thrombosis and Haemostasis 12(3): 320—328.
- Exter, P.L. den; Kroft, L.J.M.; Hartmann, I.J.C.; Hulle, T. van der; Jimenez, D.; Klok, F.A. & Huisman, M.V. (2014), Reliability of diagnosing incidental pulmonary embolism in cancer patients on contrast-enhanced staging CT not intended for pulmonary artery evaluation, Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 133: S192-S192.
- Hulle, T. van der; Tan, M.; Exter, P.L. den; Roosmalen, M.J.G. van; Meer, F.J.M. van der; Eikenboom, J.; Huisman, M.V. & Klok, F.A. (2014), Recurrence Risk after Limited Duration of Anticoagulant Treatment for Late Second Venous Thromboembolism, Blood 124(21).
- Tan, M.; Mol, G.C.; Rooden, C.J. van; Klok, F.A.; Westerbeek, R.E.; Sol, A.I. del; Ree, M.A. van de; Roos, A. de & Huisman, M.V. (2014), Magnetic resonance direct thrombus imaging differentiates acute recurrent ipsilateral deep vein thrombosis from residual thrombosis, Blood 124(4): 623-627.
- Hulle, T. van der; Exter, P.L. den; Klok, F.A.; Kroft, L.J.M.; Huisman, M.V. & Jimenez, D. (2013), Accuracy of diagnosing incidental pulmonary embolism on routinely performed contrast-enhanced CT-imaging in patients with malignancy, Journal of Thrombosis and Haemostasis 11: 736-736.
- Hulle, T. van der; Exter, P.L. den; Erkens, P.G.M.; Es, J. van; Mos, I.C.M.; Cate, H. ten; Kamphuisen, P.W.; Hovens, M.M.C.; Buller, H.R.; Klok, F.A. & Huisman, M.V. (2013), Variable D-dimer thresholds for diagnosis of clinically suspected acute pulmonary embolism, Journal of Thrombosis and Haemostasis 11(11): 1986-1992.
- Hulle, T. van der; Tan, M.; Exter, P.L. den; Mol, G.C.; Sol, A.I. del; Ree, M.A. van de; Huisman, M.V. & Klok, F.A. (2013), Selective D-dimer testing for the diagnosis of acute deep vein thrombosis: a validation study, Journal of Thrombosis and Haemostasis 11(12): 2184-2186.
- Klok, F.A. & Huisman, M.V. (2013), Seeking optimal treatment for phlegmasia cerulea dolens, Thrombosis Research 131(4): 372-373.
- Exter, P.L. den; Es, J. van; Klok, F.A.; Kroft, L.J.; Kruip, M.J.H.A.; Kamphuisen, P.W.; Buller, H.R. & Huisman, M.V. (2013), Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism, Blood 122(7): 1144-1149.
- Exter, P.L. den; Es, J. van; Klok, F.A.; Kroft, L.J.M.; Kruip, J.H.A.; Kamphuisen, P.W.; Buller, H.R. & Huisman, M.V. (2013), Risk profile and clinical outcome of symptomatic isolated subsegmental pulmonary embolism, Journal of Thrombosis and Haemostasis 11: 114-114.
- Es, J. van; Exter, P.L. den; Kaptein, A.A.; Andela, C.D.; Erkens, P.M.G.; Klok, F.A.; Douma, R.A.; Mos, I.C.M.; Cohn, D.M.; Kamphuisen, P.W.; Huisman, M.V. & Middeldorp, S. (2013), Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL, Thrombosis Research 132(5): 500-505.
- Exter, P.L. den; Roosmalen, M.J.G. van; Hoven, P. van den; Klok, F.A.; Monreal, M.; Jimenez, D. & Huisman, M.V. (2013), Physicians' management approach to an incidental pulmonary embolism: an international survey, Journal of Thrombosis and Haemostasis 11(1): 208-213.
- Pasha, S.M.; Klok, F.A.; Bijl, N. van der; Roos, A. de; Kroft, L.J.M. & Huisman, M.V. (2013), Patient delay in the diagnosis of acute pulmonary embolism does not lead to higher thromboembolic burden or worse right ventricular function, Journal of Thrombosis and Haemostasis 11: 737-737.
- Zondag, W.; Kooiman, J.; Klok, F.A.; Dekkers, O.M. & Huisman, M.V. (2013), Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis, European Respiratory Journal 42(1): 134-144.
- Exter, P.L. den; Hulle, T. van der; Lankeit, M.; Huisman, M.V. & Klok, F.A. (2013), Long-term clinical course of acute pulmonary embolism, Blood Reviews 27(4): 185-192.
- Exter, P.L. den; Es, J. van; Erkens, P.M.G.; Roosmalen, M.J.G. van; Hoven, P. van den; Hovens, M.M.C.; Kamphuisen, P.W.; Klok, F.A. & Huisman, M.V. (2013), Impact of Delay in Clinical Presentation on the Diagnostic Management and Prognosis of Patients with Suspected Pulmonary Embolism, American Journal of Respiratory and Critical Care Medicine 187(12): 1369-1373.
- Exter, P.L. den; Es, J. van; Erkens, P.M.G.; Roosmalen, M.J.G. van; Hoven, P. van den; Hovens, M.M.C.; Kamphuisen, P.W.; Klok, F.A. & Huisman, M.V. (2013), Impact of Delay in Clinical Presentation on the Diagnostic Management and Prognosis of Patients with Suspected Pulmonary Embolism, American Journal of Respiratory and Critical Care Medicine 187(12): 1369-1373.
- Huisman, M.V. & Klok, F.A. (2013), How I diagnose acute pulmonary embolism, Blood 121(22): 4443-4448.
- Exter, P.L. den; Kroft, L.J.M.; Hulle, T. van der; Klok, F.A.; Jimenez, D. & Huisman, M.V. (2013), Embolic burden of incidental pulmonary embolism diagnosed on routinely performed contrast-enhanced computed tomography imaging in cancer patients, Journal of Thrombosis and Haemostasis 11(8): 1620-1622.
- Huisman, M.V. & Klok, F.A. (2013), Diagnostic management of acute deep vein thrombosis and pulmonary embolism, Journal of Thrombosis and Haemostasis 11(3): 412-422.
- Klok, F.A.; Mos, I.C.M.; Kralingen, K.W. van; Vahl, J.E. & Huisman, M.V. (2012), Chronic pulmonary embolism and pulmonary hypertension, Seminars in Respiratory and Critical Care Medicine 33(2): 199—204.
- Pasha, S.M.; Klok, F.A.; Bijl, N. van der; Roos, A. de; Kroft, L.J.M. & Huisman, M.V. (2012), NT-pro-BNP levels in patients with acute pulmonary embolism are correlated to right but not left ventricular volume and function, Thrombosis and Haemostasis 108(2): 367-372.
- Huisman, M.V. & Klok, F.A. (2012), Magnetic resonance imaging for diagnosis of acute pulmonary embolism: not yet a suitable alternative to CT-PA.
- Mos, I.C.M.; Klok, F.A.; Kroft, L.J.M.; Roos, A. de & Huisman, M.V. (2012), Imaging tests in the diagnosis of pulmonary embolism., Seminars in Respiratory and Critical Care Medicine 33(2): 138-43.
- Exter, P.L. den; Klok, F.A. & Huisman, M.V. (2012), Diagnosis of pulmonary embolism: Advances and pitfalls.
- Klok, F.A.; Mos, I.C.M.; Kralingen, K.W. van; Vahl, J.E. & Huisman, M.V. (2012), Chronic Pulmonary Embolism and Pulmonary Hypertension, Seminars in Respiratory and Critical Care Medicine 33(2): 199-204.
- Klok, F.A.; Surie, S.; Kempf, T.; Eikenboom, J.; Stralen, J. van; Kralingen, K. van; Dijk, A. van; Vliegen, H.; Bresser, P.; Wollert, K. & Huisman, M. (2011), A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.
- Klok, F.A.; Romeih, S.; Kroft, L.J.M.; Westenberg, J.J.M.; Huisman, M.V. & Roos, A. de (2011), Recovery of right and left ventricular function after acute pulmonary embolism, Clinical Radiology 66(12): 1203-1207.
- Klok, F.A.; Romeih, S.; Westenberg, J.J.M.; Kroft, L.J.M.; Huisman, M.V. & Roos, A. de (2011), Pulmonary flow profile and distensibility following acute pulmonary embolism.
- Douma, R.A.; Mos, I.C.M.; Erkens, P.M.G.; Nizet, T.A.C.; Durian, M.F.; Hovens, M.M.; Houten, A.A. van; Hofstee, H.M.A.; Klok, F.A.; Cate, H. ten; Ullmann, E.F.; Buller, H.R.; Kamphuisen, P.W.; Huisman, M.V. & Prometheus Study Grp (2011), Performance of 4 Clinical Decision Rules in the Diagnostic Management of Acute Pulmonary Embolism A Prospective Cohort Study, Annals of Internal Medicine 154(11): -.
- Pasha, S.M.; Bijl, N. van der; Klok, F.A.; Roos, A. de; Kroft, L.J.M. & Huisman, M.V. (2011), NT-pro-BNP levels in patients with acute pulmonary embolism are correlated to right and not left ventricular volume and function, Journal of Thrombosis and Haemostasis 9: 748-749.
- Bijl, N. van der; Klok, F.A.; Huisman, M.V.; Rooden, J.K. van; Mertens, B.J.A.; Roos, A. de & Kroft, L.J.M. (2011), Measurement of Right and Left Ventricular Function by ECG-Synchronized CT Scanning in Patients With Acute Pulmonary Embolism Usefulness for Predicting Short-term Outcome, Chest 140(4): 1008-1015.
- Klok, F.A.; Mos, I.C.M.; Kroft, L.J.M.; Roos, A. de & Huisman, M.V. (2011), Computed tomography pulmonary angiography as a single imaging test to rule out pulmonary embolism, Current Opinion in Pulmonary Medicine 17(5): 380-386.
- Klok, F.A.; Surie, S.; Kempf, T.; Eikenboom, J.; Straalen, J.P. van; Kralingen, K.W. van; Dijk, A.P.J. van; Vliegen, H.W.; Bresser, P.; Wollert, K.C. & Huisman, M.V. (2011), A simple non-invasive diagnostic algorithm for ruling out chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism, Thrombosis Research 128(1): 21-26.
- Klok, F.A.; Bijl, N. van der; Eikenboom, H.C.J.; Rooden, C.J. van; Roos, A. de; Kroft, L.J.M. & Huisman, M.V. (2010), Comparison of CT assessed right ventricular size and cardiac biomarkers for predicting short-term clinical outcome in normotensive patients suspected of having acute pulmonary embolism, Journal of Thrombosis and Haemostasis 8(4): 853—856.
- Klok, F.A.; Bijl, N. van der; Mos, I.C.M.; Roos, A. de; Kroft, L.J.M. & Huisman, M.V. (2010), Timing of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism., Thrombosis and Haemostasis 104(1).
- Pasha, S.M.; Klok, F.A.; Snoep, J.D.; Mos, I.C.M.; Goekoop, R.J.; Rodger, M.A. & Huisman, M.V. (2010), Safety of excluding acute pulmonary embolism based on an unlikely clinical probability by the Wells rule and normal D-dimer concentration: a meta-analysis., Thrombosis Research 125(4): e123-7.
- Mos, I.C.M.; Douma, R.A.; Erkens, P.M.G.; Nizet, T.A.C.; Durian, M.F.; Houten, A.A. van; Hovens, M.M.; Hofstee, H.M.A.; Klok, F.A.; Cate, H. ten; Ullmann, E.F.; Buller, H.R.; Kamphuisen, P.W. & Huisman, M.V. (2010), Safety and Clinical Utility of Four Clinical Decision Rules In the Diagnostic Management of Acute Pulmonary Embolism - the Prometheus Diagnosis Study, Blood 116(21): 1309-1309.
- Klok, F.A. & Huisman, M.V. (2010), Regarding the Utility of D-dimer Testing in Patients with Suspected Pulmonary Embolism and Impaired Renal Function Reply, American Journal of Medicine 123(7): E13E13.
- Klok, F.A.; Kralingen, K.W. van; Dijk, A.P.J. van; Heyning, F.H.; Vliegen, H.W.; Kaptein, A.A. & Huisman, M.V. (2010), Quality of life in long-term survivors of acute pulmonary embolism.
- Klok, F.A.; Cohn, D.M.; Middeldorp, S.; Scharloo, M.; Buller, H.R.; Kralingen, K.W. van; Kaptein, A.A. & Huisman, M.V. (2010), Quality of life after pulmonary embolism: validation of the PEmb-QoL Questionnaire, Journal of Thrombosis and Haemostasis 8(3): 523-532.
- Klok, F.A.; Kralingen, K.W. van; Dijk, A.P.J. van; Heyning, F.H.; Vliegen, H.W. & Huisman, K.V. (2010), Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.
- Klok, F.A.; Kralingen, K.W. van; Dijk, A.P.J. van; Heyning, F.H.; Vliegen, H.W. & Huisman, M.V. (2010), Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism., Respiratory Medicine.
- Klok, F.A.; Zondag, W.; Kralingen, K.W. van; Dijk, A.P.J. van; Tamsma, J.T.; Heyning, F.H.; Vliegen, H.W. & Huisman, M.V. (2010), Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events.
- Klok, F.A.; Bijl, N. van der; Roos, A. de; Kroft, L.J.M. & Huisman, M.V. (2010), Is pulmonary embolism associated with reactive mediastinal and hilar lymphadenopathy?, Thrombosis Research.
- Kooiman, J.; Klok, F.A.; Mos, I.C.M.; Molen, A. van der; Roos, A. de; Sijpkens, Y.W.J. & Huisman, M.V. (2010), Incidence and predictors of contrast-induced nephropathy following CT-angiography for clinically suspected acute pulmonary embolism., Journal of Thrombosis and Haemostasis 8(2): 409-11.
- Klok, F.A. & Huisman, M.V. (2010), Epidemiology and management of chronic thromboembolic pulmonary hypertension, Netherlands Journal of Medicine 68(9): 347-351.
- Klok, F.A.; Bijl, N. van der; Eikenboom, H.C.J.; Rooden, C.J. van; Roos, A. de; Kroft, L.J.M. & Huisman, M.V. (2010), Comparison of CT assessed right ventricular size and cardiac biomarkers for predicting short term clinical outcome in normotensive patients suspected for having acute pulmonary embolism., Journal of Thrombosis and Haemostasis.
- Klok, F.A.; Tan, M. & Huisman, M.V. (2009), Ultrasound-Based Diagnostic Strategies for Deep Vein Thrombosis, Journal of the American Medical Association 301(9): 933-934.
- Klok, F.A.; Mos, I.C.M.; Tamsma, J.T.; Kralingen, K.W. van & Huisman, M.V. (2009), Smoking patterns in patients following a pulmonary embolism, European Respiratory Journal 33(4): 942-943.
- Mos, I.C.M.; Klok, F.A.; Kroft, L.J.M.; Roos, A. de; Dekkers, O.M. & Huisman, M.V. (2009), Safety of ruling out acute pulmonary embolism by normal computed tomography pulmonary angiography in patients with an indication for computed tomography: systematic review and meta-analysis., Journal of Thrombosis and Haemostasis 7(9): 1491-8.
- Klok, F.A.; Mos, I.C.M.; Broek, L.; Tamsma, J.T.; Rosendaal, F.R.; Roos, A. de & Huisman, M.V. (2009), Risk of arterial cardiovascular events in patients after pulmonary embolism., Blood 114(8): 1484-8.
- Klok, F.A.; Romeih, S.; Westenberg, J.J.M.; Kroft, L.J.M.; Huisman, M.V. & Roos, A. de (2009), Right ventricular reverse remodeling and pulmonary artery flow dynamics in the clinical follow-up of patients with acute pulmonary embolism: initial experience with cardiac MRI, European Heart Journal 30: 104-104.
- Bruinstroop, E.; Klok, F.A.; Ree, M.A. van de; Oosterwijk, F.L. & Huisman, M.V. (2009), Elevated d-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis, Journal of Thrombosis and Haemostasis 7(4): 611-618.
- Huisman, M.V. & Klok, F.A. (2009), Diagnostic management of clinically suspected acute pulmonary embolism., Journal of Thrombosis and Haemostasis 7 Suppl 1: 312-7.
- Karami-Djurabi, R.; Klok, F.A.; Kooiman, J.; Velthuis, S.I.; Nijkeuter, M. & Huisman, M.V. (2009), D-dimer Testing in Patients with Suspected Pulmonary Embolism and Impaired Renal Function, American Journal of Medicine 122(11): 1050-1053.
- Djurabi, R.K.; Klok, F.A.; Nijkeuter, M.; Kaasjager, K.; Kamphuisen, P.W.; Kramer, M.H.H.; Kruip, M.J.H.A.; Leebeek, F.W.G.; Buller, H.R. & Huisman, M.V. (2009), Comparison of the clinical usefulness of two quantitative D-Dimer tests in patients with a low clinical probability of Pulmonary Embolism, Thrombosis Research 123(5): 771-774.
- Klok FA, Zidane M, Djurabi RK, Nijkeuter M & Huisman M (2008), The physician's estimation 'alternative diagnosis is less likely than pulmonary embolism' in the Wells rule is dependent on the presence of other required items, Thrombosis and Haemostasis 99(1).
- Klok FA, Karamidjurabi R, Velthuis SI, Nijkeuter M & Huisman M (2008), Utility of D-dimer testing in patients with clinically suspected pulmonary embolism and elevated C-reactive protein levels, Thrombosis and Haemostasis 99(5).
- Klok FA, Djurabi RK, Nijkeuter M, Eikenboom HCJ, Leebeek FWG, Kramer MHH, Kaasjager K, Kamphuisen PW, Buller HR & Huisman MV (2008), High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity, British Journal of Haematology 140(2).
- Klok FA, Mos ICM & Huisman MV (2008), Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism - A systematic review and meta-analysis, American Journal of Respiratory and Critical Care Medicine 178(4).
- Huisman MV, Klok FA, Djurabi RK, Tormene D, Simioni P & Prandoni P (2008), Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg, Journal of Thrombosis and Haemostasis 6(3).
- Klok FA, Mos ICM, Nijkeuter M, Righini M, Perrier A, Le Gal G & Huisman MV (2008), Simplification of the Revised Geneva Score for Assessing Clinical Probability of Pulmonary Embolism, Archives of Internal Medicine -New Series- 168(19).
- Klok, F.A.; Tijmensen, J.E.; Haeck, M.L.A.; Kralingen, K.W. van & Huisman, M.V. (2008), Persistent dyspnea complaints at long-term follow-up after an episode of acute pulmonary embolism: Results of a questionnaire, European Journal of Internal Medicine 19(8): 625-629.
- Nijkeuter, M.; Tick, L.W.; Sohne, M.; Kruip, M.J.H.A.; Buller, H.R.; Leebeek, F.W.G.; Kramer, M.H.H.; Klok, F.A.; Prins, M.H.; Huisman, M.V. & Christopher Study Investigators (2008), Excluding pulmonary embolism without imaging tests - Can our diagnostic algorithm be optimized?, Thrombosis and Haemostasis 100(6): 1203-1206.
- Klok FA, Djurabi RK, Nijkeuter M & Huisman MV (2007), Alternative diagnosis other than pulmonary embolism as a subjective variable in the Wells clinical decision rule: not so bad after all, Journal of Thrombosis and Haemostasis 5(5).
- Bestuurslid, lid onderwijs
- Gastwetenschapper